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3. Summary 
 
The early B cell factor (Ebf) gene family encodes for a group of highly homologous 
transcription factors. Invertebrates, four Ebf family members (Ebf1, Ebf2, Ebf3 and 
Ebf4) have been identified. The expression of individual Ebf family members is 
largely overlapping and all Ebf transcription factors bind to the same DNA sequence. 
Consequently, their biological roles are often masked by genetic redundancy.  
 
To overcome this redundancy, a new RNAi construct was established that shows a 
high efficiency to down regulate Ebf family members (Ebf1, Ebf2 and Ebf3) 
simultaneously in cultured cells. RNAi has been developed as a powerful tool to 
silence the expression of target genes facilitating the study of specific gene function.  
A new transgenic mouse line has been generated that allows the tissue-specific 
expression of this new RNAi construct together with the marker gene Gfp. However, 
the data presented here shows no phenotypic changes in B cell development or 
neuronal differentiation of the cerebellum in the transgenic mice upon tissue-specific 
induction of the polycistronic mir155-based RNAi construct.  
 
Compared to Ebf1 and Ebf2, the biological role of Ebf3 and Ebf4 are poorly 
characterized. To determine the function of Ebf3, I contributed to the analysis of 
Ebf3-deficient mice. Ebf3 is significantly expressed in diaphragm, skeletal muscle 
and bone marrow, but not in lung and heart. Interestingly, all Ebf3 knock-out mice 
display respiratory failure, leading to their perinatal death. Ebf3-deficient mice display 
a functional defect of their diaphragm, resulting from impaired muscle relaxation.  
The SERCA1 protein, which is encoded by the Atp2a1 gene, is an ATP-dependent 
Ca2+ ion pump, which is important for the regulation muscle relaxation by transporting 
calcium ion into the sarcoplasmic reticulum. In absence of Ebf3, the expression of 
Atp2a1 is strongly down-regulated, causing the respiratory failure. Atp2a1 is a direct 
target gene of Ebf3, which cooperates with MyoD to induce Atp2a1 gene expression. 
 
Taken together, this work contributes to a better understanding of Ebf transcription 
factors by describing a new role for Ebf3 in muscle biology and developing a new 
approach to address the genetic redundancy within this gene family. 
 	  
Summary  Jeehee Kim                   
 
	   	  	  	  	  	  4	  
Zusammenfassung 
 
Die “Early B cell factor” (Ebf) Genfamilie kodiert für eine Gruppe hoch homologer 
Transkriptionsfaktoren, von denen in Wirbeltieren vier Familienmitglieder (Ebf1, Ebf2, 
Ebf3 und Ebf4) identifiziert wurden. Die Expression der einzelner Familienmitglieder 
ist großteils überlappend und alle Ebf Transkriptionsfaktoren binden an die gleiche 
DNA Bindungsstelle. Daraus ergibt sich, daß ihre biologischen Funktionen häufig 
durch genetische Redundanz kompensiert werden. 
 
Um diese Redundanz zu überwinden, wurde ein RNAi Konstrukt neu entwickelt, 
welches eine hohe Effizienz besitzt, die Expression mehrerer Ebf Familienmitglieder 
(Ebf1, Ebf2 und Ebf3) in Zellkulturen herunterzuregulieren. RNAi hat sich zu einem 
mächtigen Werkzeug entwickelt, um die Expression bestimmter Gene zu inhibieren 
und die Funktion spezifischer Gene zu untersuchen. Des Weiteren wurde eine neue 
transgene Mauslinie entwickelt, welche die gewebs-spezifische Expression des 
RNAi-Konstukts erlaubt. In der transgenen Mauslinie konnten jedoch nach Induktion 
des polycistronischen miR155-basierten Konstrukts keine phänotypischen 
Veränderungen in der B-Zellentwicklung oder in der neuronalen Differenzierung des 
Cerebellums beobachtet werden. 
Verglichen mit Ebf1 und Ebf2 sind die biologischen Rollen von Ebf3 und Ebf4 kaum 
charakterisiert. Um daher die Funktion von Ebf3 zu analysieren, untersuchten trug 
ich zur Untersuchung Ebf3-defizienter Mäuse bei. Ebf3 ist stark exprimiert in 
Skelettmuskeln, Zwerchfell und Knochenmark, jedoch nicht in Lunge und Herz. 
Interessanterweise zeigen alle Ebf3 knock-out Mäuse ein Versagen der Atmung, was 
zu ihrem Tod kurz nach der Geburt führt. Wir entdeckten, daß Ebf3-defiziente Mäuse 
an einem funktionalen Defekt des Zwerchfells litten, welcher aus einer defekten 
Muskelentspannung resultiert. Das Protein Serca1, welches eine ATP-abhängige 
Pumpe für Ca2+-Ionen darstellt und essentiell ist für die Muskelentspannung, weist in 
Abwesenheit von Ebf3 eine stark verminderte Expression auf. Atp2a1, das Gen 
welches für Serca1 kodiert, ist ein direktes Zielgen von Ebf3, das gemeinsam mit 
MyoD die Expression von Atp2a1 induziert.  
 
Zusammenfassend trägt diese Arbeit zu einem besseren Verständnis der Ebf 
Transkriptionsfaktoren bei, indem sie eine neue Rolle für Ebf3 in der Muskelfunktion 
beschreibt und ein neues Systems zur Analyse genetischer Redundanz innerhalb 
dieser Genfamilie weiter entwickelt. 
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4. Aims of the thesis 
 
I. Down-regulation of several genes simultaneously by RNAi 
in vivo 
 
In vertebrates, four of highly conserved Ebf family members have been identified. 
The overlapping expression pattern of Ebf genes masks the contribution of biological 
function of individual Ebf members by genetic redundancy. To study the biological 
role of the Ebf gene family, an RNAi-based system has been developed allowing the 
down-regulation of Ebf genes simultaneously in vitro. 
Since this system has been further developed for use in transgenic mice, the first aim 
is to analyze this new EbfmiRNA mouse line at the cellular and molecular level for 
efficiency and specificity in down-regulating Ebf genes in vivo.  
 
 
II. The biological role of Ebf3  
 
Ebf3 was identified as an important regulatory factor in neuronal differentiation. 
However, its biological role outside of the nervous system is unclear. . Therefore, the 
second aim is to gain a better understanding of the function of Ebf3 by analyzing 
Ebf3-deficient mice in non-neural tissues. 
Ebf3-deficient mice show respiratory failure caused malfunction of the diaphragm 
resulting in their perinatal death. Thus, the biochemical mechanisms of muscle 
function of diaphragm and the involvement of Ebf3 needed a detailed molecular 
analysis.  
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5. Introduction 
5.1. Early B cell factor  
5.1.1. The structure of the Ebf protein family 
 
The early B cell factor (Ebf) gene family encodes for a group of transcription factors 
that contain highly conserved domains including a DNA-binding domain (DBD), a 
transcription factor Ig-like or immunoglobulin-plexin transcription factor (TIG/IPT) 
domain and a helix-loop-helix (HLH) domain. Additionally, the Ebf family members 
contain a transcriptional-activation domain (TAD) at the carboxyl-terminus. 
In vertebrates, four members of the Ebf gene family (Ebf1, Ebf2, Ebf3 and Ebf4) 
have been identified based on the high sequence similarity of the structured domains 
(Travis et al., 1993; Hagman et al., 1995; Dubois & Vincent, 2001; Liberg et al., 2002; 
Lukin et al., 2008; Fig. 1A). Among the mouse Ebf proteins, Ebf1 and Ebf3 show the 
highest homology with Ebf2 and Ebf4 being slightly more distant (Wang et al., 1997; 
Dubois & Vincent, 2001; Liao, 2009).  
 
The DBD resides at the amino-terminus, from amino acid 50 to 251 (Liao, 2009; Fig. 
1A). The DBD includes the zinc-coordination motif (H-X3-C-X2-C-X5-C) consisting of 
14 amino acids, termed zinc knuckle (Lukin et al., 2008; Fig. 1B). This zinc knuckle is 
a particular feature of the Ebf DNA-binding domain that is crucial for DNA sequence 
recognition and binding. The DBD in total extends far beyond the zinc knuckle, and 
establishes one of the largest surfaces of interaction between a transcription factor 
and DNA currently known (Hagman et al., 1993; Fields et al., 2008; Siponen et al., 
2010; Treiber et al., 2010). Due to the high homology, all Ebf family members bind as 
dimers to the same DNA sequences that are variations of the palindromic sequence, 
5’-ATTCCCNNGGGAAT-3’ (Hagman et al., 1993; 1995). 
 
The DBD is followed by the TIG/IPT and the HLH domain. Although the main function 
of the TIG/IPT domain is still unclear, it presumably has a role in protein dimerization 
or protein-protein interactions. In ReI family proteins, for example, the main function 
of the TIG domain is to establish protein dimerization. However, in Ebf proteins, the 
TIG domain alone is not sufficient for dimerization (Aravind & Koonin, 1999; Siponen 
et al., 2010; Treiber et al., 2010). 
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The HLH domain is the main mediator of dimerization, which is a prerequisite for 
DNA binding (Hagman et al., 1993; Wang & Reed, 1993). In vertebrates, all Ebf 
family members possess a duplication of helix 2, helix 2’ (Fig. 1A), whereas 
invertebrates have only helix 1 and helix 2 without helix 2’. The interaction of helix 2’ 
with its counterpart is weaker than the interaction of the two first helices with their 
counterparts, and helix 2’ is not required for dimerization (Hagman et al., 1993; 
Crozatier et al., 1996; Siponen et al., 2010). Therefore, the exact function of the 
duplicated helix remains unclear. 
At the carboxyl-terminus, the TAD shows some variation in the number of amino acid 
and the lowest sequence homology between individual Ebf genes (Hagman et al., 
1995; Dubois & Vincent, 2001; Fig. 1A). Although the TAD is necessary for the 
transcription of most Ebf target genes, some gene promoters like mb-1 or Vpreb1 do 
not require the TAD for transactivation (Fields et al., 2008). The exact mechanisms of 
transactivation and interacting proteins have not been identified yet. 
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Figure 1. Schematic overview of conserved domains of the Ebf protein family.  
(A) Structural features of the conserved domains in Ebf proteins. All members of the Ebf 
protein family show four structured domains, which are the DBD, TIG/IPT, HLH domain and 
TAD. The DBD contains a unique zinc binding structure, termed zinc knuckle (ZN, dark blue 
box). The percentages of the sequence similarities in the DBD and TIG/IPT domain are given 
between Ebf1 and the other family members. In the HLH domain, two pink boxes indicate 
helix 1 (H1) and helix 2 (H2), and the duplication of helix 2 (H2’) is indicated as an orange 
box. At the C-terminus, the TAD shows a lower sequence homology (figure modified from 
Dubois & Vincent, 2001; Liao, 2009). (B) The structure of the zinc knuckle. The atypical Zn2+-
coordination motif consists of 14 amino acids including H157, C161, C164 and C170 (figure 
modified from Hagman et al., 1995).  
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Homologues of Ebf genes also exist in invertabrates and the best characterized 
examples are uncoordinated-3 (unc-3) in Caenorhabditis elegans and collier (Col) in 
Drosophila melanogaster. Both Unc-3 and Collier show a similar domain organization 
and extensive sequence conservation in the DBD, TIG/IPT and HLH domains (Fig. 
2). However, in the HLH domain, the duplication of helix 2 is absent (Crozatier et al., 
1996; Prasad et al., 1998; Dubois & Vincent, 2001).  
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Figure 2. Evolutionary comparison of conserved domains in Ebf proteins.  
C.elegans Unc-3 and Drosophila Collier display highly conserved domains including DBD and 
TIG/IPT domain. The percentages of identity are given between Ebf1 and its homologs. The 
DBD contains a zink knuckle (ZN). In the HLH domain of both Unc-3 and Collier, helix 1 and 2 
are conserved, but they lack helix 2’ (figure modified from Dubois & Vincent, 2001; Liao, 
2009). 
 
 
5.1.2. The biological function of the Ebf gene family 
5.1.2.1. Ebf1 
 
Ebf1 is strongly expressed in immature olfactory neuronal precursors, mature 
neurons of the olfactory epithelium and early post-mitotic neurons. This expression 
pattern indicates a potential function of Ebf1 in the development and function of the 
nervous system, particularly with respect to olfactory receptors (Wang & Reed, 1993; 
Garel et al., 1997, 2000). However, Ebf1-deficient embryos have no functional 
defects in development and function of the olfactory epithelium or early post-mitotic 
neuronal differentiation. This is likely due to the co-expression of other Ebf members, 
Ebf2 and Ebf3, which compensate for the loss of Ebf1 (Garel et al., 1997; Wang et 
al., 2004).  
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Interestingly, however, Ebf1 is the only Ebf gene expressed in the developing 
striatum (Garel et al., 1997). Ebf1-/- mice show a significant reduction in size and an 
abnormal shape of the postnatal striatum due to atrophy, indicating an essential role 
of Ebf1 in the development of the striatum (Garel et al., 1999).  
 
Additionally, Ebf1 is the only Ebf family member which expressed in hematopoietic 
cells, specifically in B cells. Ebf1-deficient mice have a complete block in B cell 
development at the pro-B cell stage. Accordingly, Ebf1 is also identified as an 
essential regulator for the differentiation of early B-lymphocytes  (Hardy et al., 1995; 
Lin & Grosschedl 1995). 
Taken together, the results from B-lymphocytes and the striatum indicate critical 
roles for single Ebf genes only when no other family member is co-expressed.  
 
 
5.1.2.2. Ebf2 
 
Another member of the Ebf gene family, Ebf2, is required for neuronal development. 
In Ebf2-deficient mice, the neuroendocrine axis is impaired causing a defect in 
pubertal development, which leads to hypogonadism. In addition, Ebf2-/- mice show a 
significantly decreased velocity of motor nerve conduction resulting in peripheral 
neuropathy  (Corradi et al., 2003).   
 
Besides its role in neuronal development, Ebf2 is also important for normal 
hematopoiesis. Ebf2 is abundantly expressed in immature osteoblastic cells, 
adipocytes, and differentiating mesenchymal stem cells. Specifically, osteoblasts 
have been implicated in the support of haematopoietic stem cells (HSC) as their 
microenvironment, termed niches, but the exact nature of these cells is unclear (Calvi 
et al., 2003; Zhang et al., 2003; Kieslinger et al., 2010; Fig. 3). 
 
Ebf2-/- embryos succeed to complete embryonic development normally, but Ebf2-null 
mice show a decreasing number of adult HSC and common lymphoid progenitors. 
Interestingly, Ebf2-expressing osteoblastic cells and HSC are in cell-cell contact at 
the bone surface. In addition, osteoblastic cells from Ebf2 knock-out mice have a 
reduced ability to maintain HSC in cell culture, demonstrating the importance of Ebf2 
for the support of HSC (Kieslinger et al., 2010).  
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Osteoblastic   
Niche Vascular Niche 
Ebf2%
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Progenitors 
Bone 
 
 
Figure 3. Schematic overview of HSC and niches in the bone marrow. 
Two different niches for HSC are currently proposed, an osteoblastic niche at the bone 
surface consisting mainly but not exclusively of osteoblasts and a vascular niche at blood 
vessels consisting mainly of perivascular cells. Both niches regulate HSC fates like 
proliferation and differentiation. Osteoblastic niche cells express Ebf2 for maintaining the 
quiescent state of HSCs, while the vascular niche cells support activated states of HSC 
(figure modified from Moore & Lemischka, 2006). 
 
 
5.1.2.3. Ebf3 
 
Ebf3 was initially identified due to its expression during neuronal differentiation (Garel 
et al., 1997; Wang et al., 1997). Specifically, Ebf3 is an important factor which 
mediates cell migration in the developing cortex and in the projection of olfactory 
neurons (Wang et al., 2004; Chiara et al., 2012). Furthermore, Ebf3 can mediate the 
inhibition of cell proliferation (Liao, 2009). The deletion of the Ebf3 in gastric cancer 
cell lines activates cell cycle arrest and apoptosis, and human EBF3 was identified 
as a tumor suppressor in gastric carcinoma (Kim et al., 2012). 
 
In Xenopus laevis, two Ebf family members, Xebf2 and Xebf3, were identified and 
Xebf3 was defined as an important regulator of neuronal differentiation (Bally-Cuif et 
al., 1998; Pozzoli et al., 2001). Moreover, both Xebf2 and Xebf3 are strongly 
expressed in developing muscle tissue in Xenopus. Overexpression of Xebf2 and 
Xebf3 leads to an up-regulation of myogenic regulatory factors including MyoD and 
Myf5, which are required for skeletal muscle development (Green & Vetter, 2011).  
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The function of Ebf3 outside of the neuronal system, however, was poorly explored 
so far. Here, in the second publication (Nature Comm., 2014), the results show that 
mammalian skeletal muscle cells express Ebf3, and Ebf3-deficient mice have a 
defect in muscle function of the diaphragm resulting in respiratory failure.  
 
 
5.1.2.4. Ebf4 	  
As the most recently identified Ebf transcription factor in vertebrates, Ebf4 was 
cloned by degenerative PCR based on its high sequence similarity with other Ebf 
family factors (Wang et al., 2002). Like other Ebf family members, Ebf4 is also 
expressed in the olfactory epithelium and neuronal tissues (Wang et al., 2002).  
Ebf4 presumably has a role regulating gene expression in olfactory sensory neurons 
as a co-regulator with other Ebf family members. However, the precise biological 
function of Ebf4 remains completely unknown (Wang et al., 2002; Lio, 2009). 
 
 
5.1.2.5. Ebf genes in invertebrates  
 
As mentioned already, homologues of Ebf genes also exist in invertebrates, such as 
Unc-3 in C.elegans and Collier in Drosophila melanogaster (Crozatier et al., 1996). 
Unc-3 is required for controlling the differentiation of both motor neurons and sensory 
neurons, leading to defect in normal motor neuron formation and correct axonal 
pathfinding in its absence, resulting in uncoordinated movement (Chalfie & 
Jorgensen, 1998; Prasad et al., 1998).  
 
Collier (Col) was initially identified at the blastoderm stage for regulating the 
differentiation of a specific head segment (Crozatier et al., 1996). Col is also 
expressed in specific subsets of post-mitotic neurons, both in the CNS (central 
nervous system) and in the PNS (peripheral nervous system) during development of 
Drosophila embryos (Crozatier et al., 1996). However, the biological role of this 
expression pattern is not defined. Moreover, Col is also required for the formation of 
a specific embryonic somatic muscle (Crozatier & Vincent, 1999) and the correct 
adult wing pattern (Vervoort et al., 1999).  
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Combining the role of Ebf factors in different organisms, a contribution to the function 
of the nervous system emerges as a unifying theme and potentially the evolutionary 
oldest role of the Ebf gene family (Crozatier et al., 1996; Dubois & Vincent, 2001). 
Other functions such as muscle development and lymphopoiesis have likely been 
acquired later on. 
 
 
5.2. Genetic redundancy 
 
Genetic redundancy means that deleting or inactivating a gene has little or no effect 
on the biological phenotype of the organism because of functional compensation by 
duplicated or highly homologous genes (Nowak et al., 1997; Cooke et al., 1997; Kafri 
et al., 2009). Multiple gene families of the mouse genome seem to originate from 
gene duplication and display a high level of sequence conservation. Therefore it is 
likely that two or more genes after duplication can be redundant. Interestingly, it is 
estimated that 10-15% of knock-out mice show no obvious phenotype or change of 
fitness, and genetic redundancy has already been demonstrated in several cases 
(Wang et al., 1996; Wang et al., 2004; Barbaric et al., 2007). 
 
A good example of this functional redundancy is the highly homologous family of Ebf 
transcription factors. The high sequence similarity and overlapping expression 
pattern of Ebf members lead to a lack of specific phenotypes upon deletion of single 
Ebf genes (Wang et al., 2004; Liao, 2009). Therefore, genetic redundancy between 
Ebf members has to be considered as an important influence when characterizing 
the biological roles of single Ebf genes. 
 
For example, the expression pattern of Ebf1, Ebf2 and Ebf3 is largely overlapping in 
mouse olfactory epithelium. Ebf1, Ebf2 and Ebf3 knock-out mice have a normal 
development of the olfactory neuronal system due to complementary function of 
other Ebf family members (Garel et al., 1999; Liberg et al., 2002). However, 
combined deletion of Ebf2 and Ebf3 results in defects in the projection of olfactory 
neurons (Wang et al., 2004). 
Furthermore, three Ebf proteins, Ebf1, Ebf2 and Ebf3, are also expressed during 
osteoblastic differentiation (Kieslinger et al., 2005, 2010). In Ebf2-/- mice, osteoblastic 
niche cells have a reduced ability to support HSC. Interestingly, down-regulation of 
three Ebf factors (Ebf1, Ebf2 and Ebf3) simultaneously leads to a stronger 
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impairment of the osteoblastic support for HSC, suggesting redundancy between Ebf 
proteins (Kieslinger et al., 2010).  
 
Another interesting case of functional redundancy is observed among myogenic 
regulatory factors (MRFs). This gene family consists of four members, MyoD, Myf5, 
myogenin and Mrf4, which are products of early gene duplication and the MRFs are 
identified as important regulators for skeletal muscle development (Wang et al., 
1996; Biressi et al., 2007; Mok & Sweetman, 2011).  
For example, both MyoD and Myf5 are expressed in myogenic precursors during 
mouse skeletal muscle development. This overlapping expression of two highly 
homologous genes compensates for the loss of function of one gene (Braun et al., 
1992; Rudnicki et al., 1992; Kablar et al., 2003). The deletion of MyoD results in a 
normal progression of skeletal muscle development in mice since it can be 
compensated for by Myf5. The other way around, the presence of a functional MyoD 
gene in Myf5-absent mice results in the normal formation of skeletal muscle. 
However, mice lacking both MyoD and Myf5 have a complete block in skeletal 
muscle development leading to postnatal death (Rudnicki et al., 1993).  
 
 
5.3.  Ebf3 and muscle development 
5.3.1. Muscle development  
 
In vertebrates, muscle cells initially differentiate from mesenchymal progenitor cells 
in the cervical somites (Birchmeier & Brohmann, 2000; Buckingham et al., 2009). As 
the somites dissociate a subpopulation of migrating progenitor cells sequentially 
starts to express the paired box transcription factors Pax3 and Pax7. This expression 
induces proliferation and expansion of this cell pool (Sato et al., 2010; Dubinska-
Magiera et al., 2013). At the same time these transcription factors are also necessary 
to induce the expression of the MRF factors Myf5 and MyoD. MRFs, basic helix-loop-
helix transcription factors, are the main inducers of skeletal muscle differentiation 
(Relaix et al., 2005; Mok & Sweetman, 2011; Fig. 4).  
 
In the vertebrate body, the most abundant tissue is skeletal muscle, which is 
essential for health and survival (Brooks & Myburgh, 2014). For example, the 
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diaphragm has a critical role for sustaining life as it is required for unfolding of the 
lung and breathing (Coirault et al., 1999b; Ackerman & Greer, 2007).  
 
MRFs are also important to coordinate the correct myogenesis of the diaphragm. 
Mice with a deletion of MyoD have a thinner diaphragm than normal mice. Myogenin-
deficient mice have an amuscular diaphragm that leads to a functional impairment of 
the diaphragm (Kablar et al., 2003). These MRFs are expressed together with 
additional transcription factors that act as co-activators of muscle-specific gene 
expression (Berkes & Tapscott 2005). In the second publication (Nature Comm., 
2014), the results show that MyoD cooperates with Ebf3 to regulate the function of 
muscle cells in the diaphragm. 
 
 
 
 
Figure 4. Diagram of mouse skeletal muscle development. 
Myogenic progenitors, expressing Pax3 and Pax7, proliferate and expand in cell number. 
Myogenic differentiation is initiated by the expression of Myf5 and MyoD inducing the fusion 
of single myoblasts into multinucleated myotubes. Finally, Myogenin and Mrf4 regulate the 
maturation of myotubes into functional muscle fibers (figure modified from Dubinska-Magiera 
et al., 2013). 
 
 
Mammalian skeletal muscle comprises two main types of fibers, which are slow-
twitch (type I) and fast-twitch (type II) muscle fibers (Biressi et al., 2007; Schiaffino, 
2012). Type I muscle fibers use oxidative metabolism and are adapted for slow 
muscle contractions, whereas type II fibers mostly utilize glycolytic metabolism for 
fast-twitch speed and have lower endurance than slow-twitch fibers. Accordingly, 
type I muscle fibers are rich in mitochondria and have increased vascularization, 
whereas type II muscle fibers have a variable mitochondrial content and a developed 
sarcoplasmic reticulum (Schiaffino & Reggiani, 2011; Ehlers et al., 2014). 
Interestingly, MyoD, a critical regulator of myogenesis, is expressed more abundantly 
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in type II muscle fibers than in type I muscle fibers (Schiaffino & Reggiani, 2011; 
Schiaffino, 2012; Ehlers et al., 2014).  
In addition, the type II fibers are divided into type IIa and type IIb. Type IIa fibers are 
oxidative metabolic fast-twitch muscle fibers which are fatigue resistant like type I 
muscle fibers. Type IIb fibers, also known as type IIx, are anaerobic, glycolytic 
metabolic fast-twitch muscle fibers which produce fast and strong force (Chalmers & 
Row, 2011; Schiaffino & Reggiani, 2011). 
 
 
5.3.2. Diaphragm 
 
The diaphragm is a dome-shaped structure formed by skeletal muscles between lung 
and abdomen. Together with the lung and the rib cage, the diaphragm is the most 
important structure to control the respiratory system (Merrell & Kardon, 2013). Its 
ability to contract and relax forces air in and out of the lung, mediating the breathing 
process (Coirault et al., 1999b; Ackerman & Greer, 2007; Stubbings et al., 2008;    
Fig. 5).  
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Figure 5.   The role of the diagram in the respiratory system. 
The respiratory system includes lung, diaphragm and rib cage. The contraction and relaxation 
of the diaphragm forces air in and out of the lungs, delivering oxygen and removing carbon 
dioxide from the body. 
 
 
Rapid and complete relaxation of the diaphragm is essential to control breathing 
frequency and oxygen uptake. Therefore, developmental defects of the diaphragm 
during embryogenesis lead to respiratory failure, causing postnatal death (Coirault et 
al., 1999b; Merrell & Kardon, 2013). In addition, impairment of diaphragm relaxation 
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leads to respiratory problems which can be involved in various diseases, such as 
fatigue, myopathy, and congestive heart failure (Esau et al., 1983; Coirault et al., 
1997; Lecarpentier et al., 1999). 
 
The diaphragm in both human and rodent has a similar morphology. The diaphragm 
consists of several different tissues including skeletal muscle, connective tissue, 
mesothelium, blood vessels, and nerves. All of its muscle cells are derived from 
migratory muscle precursor cells, which come from mesodermal cervical somites 
(Birchmeier & Brohmann, 2000; Ackerman & Greer, 2007). The boundary of the 
diaphragm is muscularized, wheareas the central region consists of tendon and has 
a distinct shape. The central tendon is attached to the liver by ligaments. Also, the 
vena cava inferior and the esophagus, which are surrounded by crural muscle, pass 
through the central part of diaphragm (Sweeney, 1998; Birchmeier & Brohmann, 
2000; Vasyutina & Birchmeier, 2006; Ackerman & Greer, 2007).  
 
Unlike many skeletal muscles in the body, diaphragm is constantly active and most 
of muscle fibers in diaphragm are consisted of type I and type IIa which are relatively 
resistant to fatigue (Stubbings et al., 2008). 
 
 
5.3.3. Muscle function of the diaphragm 
 
The molecular machinery involving Ca2+ transport controls muscle contraction and 
relaxation. In mammalian muscle fibers, sarcoplasmic reticulum (SR) is the most 
important intracellular compartment for the storage of Ca2+ (Coirault et al. 1999; 
Carafoli, 2002; Clapham, 2007).  
 
Release of the stored Ca2+ from the SR to the cytoplasm results in muscle 
contraction. On the contrary, when Ca2+ is taken up from the cytoplasm into the 
lumen of the SR, the low level of cytosolic Ca2+ induces muscle relaxation (Coirault et 
al. 1999; Carafoli, 2002; Clapham, 2007; Fig. 6). The import of Ca2+ into the SR is 
controlled by Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) proteins, which 
are encoded by various Atp2a genes (Olson et al., 2010; Inesi & Tadini-Buoninsegni, 
2014).  
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In the adult diaphragm, two different isoforms of SR Ca2+-ATPase, SERCA1 and 
SERCA2a have been detected (Sayen et al., 1992; Anger et al., 1995). SERCA1 is 
exclusively expressed in fast-twitch skeletal muscle fibers, whereas SERCA2a is 
expressed in slow-twitch muscle fibers as well as in cardiac and smooth muscles 
(Lytton et al., 1992; Coirault et al., 1999b). SERCA2a is also regulated by another 
integral membrane protein, phospholamban. The unphosphorylated phospholamban 
decreases the affinity between Ca2+ and SERCA (MacLennan et al., 1992; Coirault et 
al., 1999b; MacLennan, 2000). 
 
SERCA1-deficient mice display cyanosis due to respiratory failure resulting in 
postnatal lethality. The lack of SERCA1 in fast-twitch skeletal muscle leads to a 
reduced Ca2+ pump activity to transport Ca2+ into the SR. Accordingly, the loss of the 
function of SERCA1 Ca2+ pump causes the impairment of relaxation of the skeletal 
muscle. This phenotype resembles a genetic myopathy in humans, Brody disease, 
which leads to defects in muscle relaxation, muscle stiffness, cramping and a 
shortened lifespan (Odermatt et al., 1996; MacLennan, 2000; Pan et al., 2003). 
In the second publication (Nature Comm., 2014), Atp2a1 is described as a direct 
target gene of Ebf3, demonstrating that Ebf3 is required for muscle relaxation in the 
diaphragm. 
 
	   	  	   	  
Figure 6. The mechanisms of muscle contraction and relaxation. 
The energy-dependent transport of Ca2+ regulates muscle function. Release of Ca2+ from the 
sarcoplasmic reticulum (SR) to the cytoplasm causes muscle contraction. Muscle relaxation is 
achieved by the ATP-dependent transport of Ca2+ ions by SERCA proteins into the SR lumen 
(figure modified from Coirault et al., 1999b). 
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5.4. RNA interference 
5.4.1. MicroRNA  
 
MicroRNAs (miRNAs) have important roles in several biological processes including 
developmental timing control, hematopoiesis, apoptosis, cell proliferation and 
differentiation (Ambros, 2004; Barter, 2004). The first miRNA, lin-4, was discovered 
in C. elegans as a non-protein-coding small RNA that controls timing of C. elegans 
larval development (Lee et al., 1993). Meanwhile, hundreds of noncoding miRNA 
genes mediating gene-silencing have been identified (Lee et al., 2004; Murchison & 
Hannon, 2004; Kim 2005). To down-regulate specific gene expression, miRNAs can 
bind to complementary sites in target mRNAs frequently in the 3’-untranslated region 
(UTR) preventing protein synthesis (Lee et al., 1993).  
 
miRNAs are tiny single-stranded RNAs ranging between 19-25 nucleotides in length 
(Ambros et al., 2003; Bartel, 2004). Compared to miRNAs, small interfering RNAs 
(siRNA) are a different type of small RNA consisting of a short duplex with 21-28 
nucleotides (Kim et al., 2003, 2005). MiRNAs are processed from transcripts which 
contain a local hairpin structure, while siRNAs are made from long double-stranded 
RNA (dsRNA). The RNase III protein Dicer recognizes and cleaves the miRNA 
precursor and dsRNA into miRNA and siRNA (Ambros et al., 2003; Kim, 2003).  
Because these two classes of small RNAs, siRNAs and miRNAs, are generated by 
the same RNAi pathway in cells, it is difficult to distinguish them by means of their 
biochemical properties (Kim et al., 2003; Bartel, 2004; Ventura et al., 2004).  
 
Both miRNAs and siRNAs are key players in the RNA silencing process, and 
although they share many aspects in their biogenesis, some characteristics are 
different. MiRNAs are classified as hetero-silencing RNAs that are derived from a 
different genomic locus than its targets. siRNAs are classified as auto-silencing 
RNAs that originate from the same genomic locus including mRNAs, transposons, 
viruses, or heterochromatic DNA (Bartel, 2004; Mack, 2007). Also, several different 
classes of endogenous siRNAs were discovered in various organisms (Kim et al., 
2003, 2005). 
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5.4.2. RNA interference process 
 
The RNAi pathway was originally found in C. elegans to silence specific gene 
expression (Fire et al., 1998). However, RNAi processing is not only a phenomenon 
in C.elegans, but constitutes an evolutionarily conserved mechanism for the down-
regulation of target genes in many different organisms including vertebrates and 
plants (Kennerdell & Carthew, 1998; Wianny & Zernicka-Goetz, 2000; Kunath et al., 
2003; Ventura et al., 2004). Thus, RNA interference (RNAi) also represents a 
powerful tool to silence gene expression in a sequence-specific manner.  
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Figure 7. The RNA interference process. 
(A) The biogenesis of miRNAs. In the cell nucleus, miRNA genes encode for the primary 
miRNA transcripts (pri-miRNAs) which are transcribed by RNA polymerase II. Drosha 
recognizes and cleaves the short hairpin structure of the pri-miRNA, generating pre-miRNAs 
(figure is modified from Kim, 2003). (B) RNA interference pathway. In the cytoplasm, Dicer 
cuts the double-stranded pre-miRNA to produce the siRNA. The siRNA is incorporated into 
the RISC complex which targets mRNA. The complementary mRNA to the siRNA is cleaved 
by active RISC (figure is modified from Kim, 2003). 
 
 
Introduction 	   Jeehee Kim 
	   20	  
In the nucleus, the endonuclease Drosha recognizes a stem loop in the long primary 
miRNA transcripts (pri-miRNAs) and cleaves the short hairpin structure, converting it 
into the miRNA precursor pre-miRNA (Lee et al., 2002; Kim, 2004; Fig. 7A). This 
cleaved pre-miRNA is exported from the nucleus to the cytoplasm by the Ran-
dependent nuclear transport receptor exportin-5 (Yi et al., 2003; Lund et al., 2004).  
 
In the cytoplasm, the pre-miRNA is processed into the mature miRNA by another 
endonuclease, Dicer (Hutvagner et al, 2001; Bernstein et al., 2001; Grishok et al., 
2001). Dicer converts the pre-miRNA into the short double-stranded siRNA 
consisting of 21-22 nucleotides (Fire et al., 1998; Hamilton and Baulcombe, 1999; 
Bernstein et al., 2001). The RNA-induced silencing complex (RISC) is recruited to 
the single strand of siRNA as one ribonucleoprotein compound. The RISC 
endonuclease, AGO2 detects the sequence-complementary mRNA and cleaves it. 
Finally, this cleaved mRNA is degraded by other endogenous nucleases leading to a 
specific down-regulation of gene expression (Elbashir et al., 2001; Fig. 7B). 
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Introduction
One of the surprising findings of gene targeting in mice are
knock-out animals with no obvious phenotype. While a
proportion of these cases is likely due to incomplete phenotypic
testing or a manifestation only under certain non-standard
conditions, it is estimated that 10 - 15% of knock-out mice do
not have an obvious phenotype [1]. The vast majority of such
cases is thought to derive from functional redundancy between
duplicated and highly homologous genes [2]. In favour of this
hypothesis, duplicate genes occur in all organisms, especially
in multicellular eukaryotes with approximately 50% of mouse
genes having a related member in the genome [3–5]. While
these facts have interesting and sometimes hard to reconcile
implications for evolutionary biology [6,7], gene duplications
and redundancy often mask the true contribution of single
genes, making it difficult to discern the function of each copy by
knocking out individual genes [8].
Interestingly, conserved gene duplicates in vertebrates are
specifically enriched for signal transduction and developmental
function [9]. Good examples of this are the MRF family of
transcription factors, acting as master regulators of vertebrate
skeletal muscle development, and the Hox gene cluster [10].
Another interesting case is the early B cell factor (Ebf) family of
transcription factors. All four members show a high level of
sequence conservation, reaching 80 - 90% at the nucleotide
level within conserved domains, and all four members bind to
the same DNA sequence [11,12]. Despite a strong expression
in tissues like the olfactory epithelium and in many neuronal
cells, deletion of Ebf1 results in a distinct phenotype, i.e. the
complete block of early B cell development [13]. This finding
was unexpected, but Ebf1 is the only family member expressed
in hematopoietic cells, whereas the tissues mentioned above
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express other Ebf genes in a largely overlapping manner
[14–17]. In fact, in addition to B cells, Ebf1 is the only Ebf gene
expressed in the embryonic striatum and in cranial nerve
nuclei, and Ebf1-deficient mice display atrophy and abnormal
cellular migration, axonal fasciculation and projection [18–20].
Ebf2 and Ebf3 are also expressed in a largely overlapping
pattern, and deletion of the single genes leads to a mixture of
distinct and overlapping phenotypes causing lethality at the age
of approximately two months or immediately after birth
respectively. Ebf2 null mice display abnormalities in the
cerebellum and peripheral nerve [21,22]. Mice double
heterozygous for Ebf2 and Ebf3 recapitulate common defects,
such as defective projection of olfactory neurons, but do not
display some of the defects occurring only in single knock-outs,
arguing that the function of Ebf genes is dose-dependent and
at least partially redundant [23].
In an effort to overcome functional redundancy and examine
the contribution of Ebf factors in general to the support of
hematopoietic stem cells, we employed the SIBR (synthetic
inhibitory BIC-derived RNA) vectors, a new approach to down-
regulate several genes simultaneously based on RNA
interference [24]. In this system shRNA sequences are
embedded into the framework of miR155/BIC including the
flanking sequences, which are cleaved by the RNAseIII
enzyme Drosha. This allows the concatemerisation of several
shRNAs, and the inclusion of a marker gene, in our case Gfp.
Furthermore, regulated expression of the RNAi construct is
possible since it uses RNA polymerase II-driven promoters.
Overall, this results a flexible system to express several
shRNAs together with a marker gene in a single polycistronic
mRNA driven by PolII [25]. We were able to successfully down-
regulate Ebf1, Ebf2 and Ebf3 and to demonstrate redundancy
between these genes in retrovirally infected cultures of
osteoblastic cells [24]. The same vector has been used also by
other groups to inhibit the Ebf proteins in a variety of different
cells [26,27]. As this system proved useful in cell culture
approaches in different contexts, we wanted to develop it
further and overcome the limitations of in vitro approaches and
retroviral infections. Here, we report the generation of
transgenic mice with a targeted insertion of the SIBR-based
EbfRNAi construct into the murine Rosa26 locus, and describe
the effects of its induced expression.
Results
Generation of EbfmiRNA transgenic mice
The successful down-regulation of Ebf1, Ebf2 and Ebf3 using
one miRNA construct allowed us to analyse the biological
effects of this highly conserved protein family in cell culture
[24]. While this approach opens new possibilities in studying
biological roles independent of redundancy, it remains limited
to in vitro assays and the expression of the miRNA construct
via transfection or viral infection. To overcome these limitations
we wanted to develop this system further and use it in vivo by
generating mice with a targeted insertion. We had previously
generated two different miRNA constructs, RNAi-a and RNAi-b,
targeting the mRNAs of Ebf1, Ebf2 and Ebf3 at different
positions, primarily to control for off-target effects of the miRNA
generated [24,28]. The single shRNAs bind to regions of the
Ebf mRNAs corresponding to the DNA binding or the adjacent
IPT/TIG-domain (of unknown function) of the encoded proteins
(Figure S1A) and are concatemerised as indicated (Figure
S1B). Therefore, as two different constructs were available, we
wanted to analyse the effectiveness of the RNAi constructs in
detail before going in vivo. Therefore, HEK293T cells were
transfected with expression plasmids for flag-tagged Ebf1, Ebf2
and Ebf3. In parallel, all six single constructs (two per Ebf
gene), double and triple constructs were co-transfected. Co-
expression of the single RNAi constructs resulted in the down-
regulation of the respective Ebf protein, but left the other family
members relatively unaffected, indicating specificity but also a
high level of effectiveness. The double RNAi constructs against
Ebf2 and Ebf3 led to their strong down-regulation, but left Ebf1
relatively unchanged, demonstrating that neither specificity nor
effectiveness are compromised by the concatemerisation via
the flanking region of miR155. Finally, expression of the triple
RNAi constructs induced a loss of Ebf proteins to almost
undetectable levels (Figure S2). Although the single RNAi
constructs seemed to show slight differences in down-
regulation efficiencies, these were minor and could be due to
experimental variances. In fact, no differences were observed
with the double and triple constructs, confirming data from the
down-regulation of endogenous Ebf proteins [24]. Therefore,
we decided to use both constructs for the generation of
targeted mouse ES cells.
Since miRNAs are standard class II mRNAs driven by RNA
polymerase II [29], yet depend on strong expression, we
decided to target the insertion to the Rosa26 locus. However,
instead of relying on the endogenous transcriptional activity of
the locus we decided to use the synthetic CAG (CMV early
enhancer/ chicken β-actin) promoter, which has very strong
transcriptional activity [30,31]. In combination with a
transcriptional Stop site and a PGK::Neo resistance cassette,
both flanked by loxP sites, immediately downstream of the
CAG promoter (Figure 1A), this construct allows strong and
tissue-specific expression of the insert [32]. The insert, which
follows immediately after the loxP sites consists of the Gfp
gene and the short hairpin sequences concatemerised by the
flanking region of miR155 (Figure 1A). This sequence was cut
from the pcDNA6.2-GW/EmGFP vector that was described
before [24], and is also analysed here (Figure S2).
The targeting construct was used for electroporation of
IDG3.2 murine ES cells, which were selected by G418. 600
resistant ES cell clones were picked and analysed for correct
integration of the construct by Southern blot. In case of the
external 5' probe, the appearance of a 6kb band in an EcoRI
digestion and of a 12 kB band with a ScaI digestion indicates
the correct integration of the construct. Figure 1B shows two
clones with integration of the RNAi-A (A-xx) and two clones
with integration of the B construct (B-xx). Hybridising Southern
Blot to the internal Gfp probe results in the predicted bands of 3
kb for the EcoRI digest and 12 kb for the ScaI digest,
confirming the correct and unique integration of the targeting
vector (Figure 1C). In addition to the Southern Blot, all positive
clones were also confirmed by sequencing. Overall, a 7.5%
targeting efficiency was achieved over 600 clones tested,
Multi-Gene Knockdown by RNAi
PLOS ONE | www.plosone.org 2 November 2013 | Volume 8 | Issue 11 | e80312
Figure 1.  Generation of EbfmiRNA transgenic murine ES cells.  (A) Schematic representation of the Rosa26 wild-type locus. A
solid line represents regions involved in the targeting construct, while a dashed line depicts genomic regions beyond the targeting
construct. The targeting strategy consists of inserting the transgene into the XbaI site in intron 1, which is flanked by homology arms
including exons1, 2 and 3. The transgene consists of the synthetic CAG-promoter, a PGK::Neo cassette with a transcriptional Stop
sequence flanked by loxP sites, the RNAi insert as a black box, and a polyA sequence. In the third line the insert is detailed as
consisting of the Gfp gene, and DNA sequences encoding for short hairpin mRNA against Ebf3, Ebf2 and Ebf1. These sequences
are surrounded by the flanking region of miR155, which is recognised by the ribonuclease Drosha. The locus after recombination is
depicted in line 4, also indicating the direction of transcription from the CAG promoter and the PGK::Neo-Stop cassette.
Endogenous and newly introduced restriction sites are indicated and the resulting fragment lengths for wild-type and targeted allele
with specific restriction enzymes are given. Southern blot probes corresponding to the 5’ region and to the Gfp gene are indicated.
(B) Southern blot of genomic DNA from one wild-type and four mutant ES cell clones digested with EcoRI and ScaI as indicated,
and hybridised to the 5´ probe (as shown in A). Bands corresponding to the wild-type (wt) and the targeted (int) allele are indicated.
(C) Southern blot of genomic DNA as in B, hybridised to the internal Gfp probe. Bands of the correct size appear in all four targeted
ES cell clones as indicated.
doi: 10.1371/journal.pone.0080312.g001
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confirming the high recombination efficiency published for this
locus [33,34].
No leakiness and high inducibility of the transgene in
murine ES cells
To test the transgene functionally before going in vivo, we
transfected ES cell clones with the pGK-cre-bpA plasmid (kind
gift of Dr. Kurt Fellenberg, Institute of Genetics, University of
Cologne), which leads to the expression of the Cre-
recombinase in transfected cells. In consequence, the
transcriptional Stop sequence should be deleted and the
transgene including the Gfp gene should come under control of
the CAG promoter (Figure 2A). ES cells were harvested 48h
post-transfection and analysed by flow cytometry for the
expression of Gfp. Figure 2B indicates that cells transfected
with the mock vector do not express Gfp, and a low percentage
of cells shows apoptosis as detected by propidium iodide.
Transfection of the Cre-encoding plasmid however, leads to an
expression of Gfp in approximately 30% of cells, again with a
low percentage of cells showing apoptosis (Figure 2B). This
indicates that the construct is not leaky, i.e. there is no
expression of the transgene in presence of the Stop sequence,
and that the transgene is efficiently induced via Cre-mediated
excision of the Stop cassette. Furthermore, expression of the
transgene does not influence viability of the cells.
No leakiness, high inducibility and strong expression
of the transgene in vivo
Since all tests in ES cells provided evidence for the correct
insertion and the functioning of the transgene, we proceeded to
generate transgenic mice by standard conditions. Two different
ES cell clones for each RNAi construct were injected into
blastocysts and chimeric mice were obtained with both
transgenic constructs, RNAi-a and RNAi-b. However, germ-line
transmission was only successful with chimeric mice transgenic
for the RNAi-a construct. As RNAi-a and RNAi-b did not differ
significantly in their ability to down-regulate Ebf proteins in vitro
(Figure S2 and [24]), we continued to analyse these mice and
will refer to them as Rosa26RNAi.
To determine leakiness, inducibility and functionality in vivo,
we wanted to induce expression of the transgene in
hematopoietic cells. Ebf1 is expressed in early B cells and is
necessary for the transition from fraction A to fraction B during
B cell development [13]. Furthermore, miRNAs and the protein
machinery required for their processing are important for the
development of other hematopoietic cells like T and B cells
[35]. Thereby, the functionality of the transgene can be tested
in early B cells and potentially unspecific or off-target effects by
examining T cell development, making the hematopoietic
system ideal to study both aspects. To this end, we crossed the
Rosa26RNAi mouse line to the vavCre line, which is active in
hematopoietic stem cells and their derivatives [36]. In a first
analysis, we wanted to determine the inducibility and the level
of expression of the transgene, as these are two critical
parameters for the effectiveness of RNAi. Single cell
suspension from the bone marrow of adult mice from various
genotypes was analysed by flow cytometry for the expression
of Gfp. In all control mice, wt::wt, wt::Rosa26RNAi/+ and
vavCre::wt, no expression of Gfp and a percentage of
approximately 50% B220-positive cells could be detected,
indicating again no leakiness of the construct. A small
reduction in the number of B220-positive cells was observed in
the presence of the recombinase, but this phenotype did not
reach statistical significance, therefore it might represent a
slight tendency, but does not proof phenotypic changes due to
the expression of the Cre recombinase. The vast majority of
bone marrow from vavCre::Rosa26RNAi/+ is shifted into the Gfp
positive channel, with virtually all B220-positive cells also
expressing Gfp. The level of expression of Gfp varies between
several different populations, but ranges between one to three
shifts in logarithmic units above wild-type, with the majority of
cells at around two log-shifts (Figure 3A). Bone marrow cells
from vavCre::Rosa26RNAi/RNAi show exactly the same pattern of
Gfp-positive cells when plotted against B220, but the
expression of Gfp is shifted to even higher levels, with very few
cells remaining negative for Gfp (Figure 3A). Statistical analysis
shows that the described differences in the expression of Gfp
are highly significant, and also indicate that the number of
B220-positive cells is reduced from 53.8% in wild-type animals
to 40.4% in vavCre::Rosa26RNAi/+ and 38.6% in
vavCre::Rosa26RNAi/RNAi mice, indicating a potential but weak
influence of the transgene on B cell development (Figure 3B).
No alterations in early B cell fractions mediated by
expression of the transgene
As we detected a high expression of the transgene,
particularly in B cells and a slight reduction of B220-positive
cells, we continued to analyse the functionality of the RNAi
transgene. Since Ebf1 is the only Ebf family member
expressed in haematopoietic cells and is required for the
progression from fraction A to fraction B in early B cell
development [13], we expected a block or at least a down-
regulation of cells in the transition from fraction A to fraction B,
depending on the efficiency of the construct. Single cell
suspensions from mice of the indicated genotypes were
stained for B220 and CD43, and double positive cells, which
comprise fractions A - C were analysed. No differences in the
percentage of these cells were detected (Figure S3). For
further analysis, these cells were gated and analysed for
expression of BP-1 and CD24, allowing the individual fractions
to be distinguished. Again, no differences beyond standard
variations in fractions A (BP-1-CD24-), B (BP-1-CD24+), or C
(BP-1+CD24+) could be detected in the various genotypes
(Figure 4A). Statistical analysis confirms this for all fractions
tested. Neither in the B220+CD43+ Fractions A - C, nor in the
individual fractions is it possible to detect any significant
changes (Figure 4B).
Expression of the transgene does not interfere with
Ebf1 levels in vivo
As no differences in early B cell fractions could be detected
in hematopoietic cells, yet the cells express the transgene, we
wanted to determine the levels of Ebf1 under these conditions.
Therefore, we sorted fractions A, B and C according to the
sorting gates indicated in Figure 5 A from mice carrying the
same genotypes as before. Analysis of these early B cell
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Figure 2.  The transgene shows no leakiness and high inducibility in murine ES cells.  (A) Schematic depiction of the
transgene inserted into the Rosa26 locus. Expression is driven by the strong CAG promoter, but aborted due to the presence of the
transcriptional Stop sequence. Upon Cre mediated deletion, the stop cassette is removed and a polycistronic mRNA encoding for
Gfp and short-hairpin sequences against Ebf3, Ebf2 and Ebf1 gets expressed. (B) ES cell clones tested by Southern blot as
correctly targeted for either the RNAi-a or RNAi-b construct were transfected with the pGK-Cre-bpA plasmid encoding for the Cre
recombinase or with the empty parental vector (mock). 48 h after transfection, cells were analysed by FACS for the expression of
Gfp and for cell death by propidium iodide. Cells have been gated for FSC/SSC.
doi: 10.1371/journal.pone.0080312.g002
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Figure 3.  No leakiness, high inducibility and strong expression of the transgene in vivo.  (A) Single cell suspensions from
bone marrow of mice with the indicated genotypes were analysed for the expression of Gfp and the B cell marker B220. Gfp-positive
cells are observed only in combination of the vavCre and the transgenic Rosa26RNAi genotypes. All other genotypes show expression
of B220, but a lack of Gfp. Note the slight shift in expression of Gfp from Rosa26RNAi/+ to Rosa26RNAi/RNAi, due to the presence of two
alleles of the transgene. Cell have been gated for FSC/SSC and as PI-. (B) Statistical analysis of bone marrow cells stained and
analysed as in A. Significant differences based on genotypes are observed only in combination of the vavCre and Rosa26RNAi
transgenes compared to all other genotypes; n=3-4; error bars=SD; ** p<0.01, *** p<0.001.
doi: 10.1371/journal.pone.0080312.g003
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Figure 4.  No alterations in early B cell fractions mediated by expression of the transgene.  (A) Single cell suspensions from
bone marrow of mice with the indicated genotypes were analysed for the percentage of early B cell fractions. Cells were stained
with propidium iodide, B220, CD43, BP-1, HSA and CD24. Propidium iodide negative cells are gated as B220/CD43 double positive
(see Figure S3), and analysed for expression of HSA/CD24 allowing to distinguish fractions A (B220+CD43+CD24-BP-1-), B
(B220+CD43+CD24+BP-1-) and C (B220+CD43+CD24+BP-1+) of B cell development. Representative examples of the indicated
genotypes are shown. Cells were further gated for FSC/SSC. (B) Statistical analysis of bone marrow cells stained and analysed as
in A. No significant differences based on genotypes are observed; n=3-4; error bars=SD.
doi: 10.1371/journal.pone.0080312.g004
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fractions for the expression of Ebf1 revealed no significant
differences in the amount of mRNA even in vavCre::Rosa26RNAi/+
versus vavCre:: Rosa26RNAi/RNAi mice (Fig. 5B). Since RNAi can
also inhibit protein translation, we tested the protein levels of
early B cells. As the number of cells after fractionation is too
low to allow for testing of individual fractions, we sorted
B220+CD43+ fractions A - C, and subjected those to Western
blot analysis. Using a pan Ebf antibody recognising Ebf1, Ebf2
and Ebf3, we could detect comparable amounts of Ebf protein
in cells from all genotypes. For control, bone marrow
mononuclear cells were depleted of B220+ cells and included in
the assay. No band was detected in these cells, confirming that
no Ebf protein is expressed in hematopoietic cells besides Ebf1
in B cells (Figure 5C). Quantification of the protein amount by
densitometry confirmed this observation by showing that no
significant differences in Ebf protein levels exist based on the
various genotypes (Figure 5D). Therefore we conclude that
although the transgene mediates down-regulation of Ebf
proteins in cell culture, and it is expressed at high levels in B
cells from transgenic mice, its expression does not affect Ebf1
protein levels in vivo.
No alteration in cerebellar cyto-architecture in the
Ebf2GFPiCre::Rosa26RNAi line
Previous studies have clearly indicated that targeted deletion
of one member of the Ebf gene family (Ebf2) impairs cerebellar
development. In particular, cerebellar Purkinje cells (PCs) are
decreased in number affecting the size and lobulation of the
null cerebellum. One PC subpopulation is selectively reduced,
and PC migration into the cerebellar cortex is impaired or
delayed [21,37]. Ebf2 exerts an autocrine/paracrine control
over PC survival by activating Igf1 gene expression [27]. In
light of these previous findings, we tested the combined effect
of Ebf1-3 down-regulation on cerebellar development. This
analysis was conducted on the adult (P60) progeny of an
Ebf2Cre x Rosa26RNAi/+ cross. Ebf2-Cre is activated at the outset
of PC development, and robust Cre levels are detected in the
cerebellar primordium as early as E11.5 [26]. This transgene
marks the PC lineage, as shown by genetic fate mapping (A.B.,
unpublished observations). Our results clearly indicate that
Ebf2Cre::miRNA+/- mice feature no major cerebellar defects
(Figure 6A-D). DAPI staining indicated that cerebellar
lobulation is unaffected by RNAi activation in PC progenitors.
Moreover, transgenic PCs express normal levels of Calbindin
(CaBP), a Ca2+ binding protein whose levels decrease rapidly
upon PC degeneration. Finally, RNAi-expressing PCs exhibit a
normally branched dendritic tree. Thus, no obvious
abnormalities were scored in RNAi-expressing cerebella.
Expression of Gfp and the miRNA-transgene are
correlated but do not influence Ebf protein levels
The data indicate a clear discrepancy between the
functionality of the construct in vitro and in vivo. One possible
explanation is an insufficient expression level of the transgene.
So far we have analysed Gfp-positive cells as one bulk
population, but as shown in Figure 3A, the expression of Gfp
shows a broad spectrum, from high to low expression in largely
three distinct populations. This offers the possibility to analyse
these populations individually, to examine if expression-related
effects are masked in the bulk analysis. To this end, we
isolated low, middle and high Gfp-expressing cells in addition
to Gfp-negative cells by flow cytometry from vavCre::miRNA+/-
and vavCre::miRNA-/- mice. Interestingly, the percentage of cells
in the respective gates does not differ between these two
genotypes, but the expression of Gfp is clearly higher in
vavCre::miRNA-/-, reflecting the presence of two instead of one
allele of the transgene (Figure 7A).
The expression of the transgene in these sorted populations
was analysed in qPCR by primers spanning from the 3'-end of
Gfp to the last inserted miRNA sequence. As shown in Figure
7B, Gfp-negative cells from all examined genotypes displayed
no detectable expression of the transgene, while cells from
gates 2 - 4 show increasing expression of the transgene
(Figure 7B), revealing a correlation in the expression of the
transgene with Gfp. Therefore, if expression plays a role, we
might be able to see an influence on Ebf1 protein levels in the
most highly expression populations. However, western blot
analysis of cells sorted according to the gates showed that
Ebf1 was present in the different fractions at comparable levels
(Figure 7C), indicating that too low expression of the transgene
alone does not explain the observed inefficiency in vivo.
Discussion
RNAi has evolved as a means to down-regulate the
expression of single target genes in vivo [38]. Initially, short-
hairpin RNAs were driven by RNA polymerase III-dependent
promotors to affect the expression of a single target gene
[39–44]. Tissue-specificity can be achieved via the disruption of
the promotor by a neomycin-resistance cassette flanked by
loxP sites [45–47]. However, neither does this system allow to
incorporate a marker gene, nor to choose the activating
potential of the promotor. When it was found that over-
saturation of the cellular shRNA/miRNA pathway was sufficient
to cause morphologic changes and even fatality in mice, it
became clear that a regulated expression was important in vivo
[48]. At the same time, shRNA sequences were discovered that
are embedded in more complex RNAi transcripts, which are
driven by RNA polymerase II, opening the possibility of tissue-
specific expression and inclusion of a marker gene [29,49,50].
Among those, miRNA30 was first shown to mediate inhibition
of cognate mRNAs with natural as well as designed miRNA
sequences [51]. This system was developed further, and now
allows the down-regulation of target RNAs in a tissue-specific
and, by adding a doxycycline-inducible promoter, reversible
manner [52–54].
In some situations however, as to overcome genetic
redundancy or to inhibit more than one signalling pathway, it is
desirable to inhibit several genes concomitantly. The miR155
precursor is embedded within the third exon of the non-coding
BIC gene, and the miR155 precursor together with flanking
regions is sufficient to confer the oncogenic activities of BIC/
miR155 [55,56]. Based on this, a polycistronic expression
vector for RNA polymerase II was developed, in which the
flanking regions, which are subject to cleavage by the RNAse
Drosha, are used to concatemerise sequences encoding
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Figure 5.  Expression of the transgene does not interfere with Ebf1 levels in vivo.  (A) Single cell suspensions from bone
marrow of mice with the same genotypes as before were prepared and stained for B220/CD43 and CD24/BP1. Cells were gated in
flow cytometry for FSC/SSC and as B220+CD43+ as indicated in the left panel in a representative example. The right panel shows
the gates used for sorting of cells from fraction A (B220+CD43+CD24-BP-1-), B (B220+CD43+CD24+BP-1-) and C
(B220+CD43+CD24+BP-1+). These B cell fractions were sorted from all the genotypes used throughout this study. (B) Sorted cells
from different B cell fractions of the indicated genotypes were subjected to qPCR analysis of Ebf1. All values were normalised to
HPRT and the expression of Ebf1 in wild-type cells was set to 1 in each case; n=3-4; error bars=SD. (C) B220+CD43+ cells were
sorted from total bone marrow of mice with the indicated genotypes and used for analysis of expression of Ebf1 by Western blot
(Fractions A-C). Bone marrow from wild-type mice was depleted of B220+ cells (B220- BMMNC) and used as negative control, β-
actin is used as loading control. (D) Measurement of the amount of protein present in the B cell fractions and control as depicted in
C using ImageJ; n=3-4; error bars=SD, ** p<0.01.
doi: 10.1371/journal.pone.0080312.g005
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shRNAs [25]. At least two different synthetic shRNAs can be
expressed from a single transcript and coupling to a marker
gene like Gfp is possible without compromising the efficiency of
the system. We used this framework to incorporate sequences
directed against Ebf1, Ebf2 and Ebf3 and observed a strong
down-regulation upon ectopic expression but also of the
endogenous genes, allowing us to establish a redundant role of
these proteins in the support of hematopoietic stem cells [24].
As these constructs also worked in various other cellular
contexts [26,27], we wanted to extend the system and to
overcome the limitations of cell culture and retroviral infections.
The most striking finding of our experiments is that an RNAi
construct that mediates down-regulation of cognate RNA very
efficiently in cell culture does not have a biological effect in
vivo. Several possibilities with different likelihoods can explain
this discrepancy. One of our major concerns was the level of
expression necessary to achieve a down-regulation in vivo.
Originally, one of the reasons for choosing RNA polymerase III
for the expression of shRNAs was the high level of expression
that can be achieved. Therefore, we did not want to rely on the
expression mediated by the endogenous Rosa26 locus, which
ranges from low to mid level, depending on cell type, but is not
near typical RNA polymerase III or viral promotor driven
expression [57,58]. Therefore, we chose the synthetic CAG
promotor, which is among the strongest inducers of eukaryotic
expression known [31]. We do observe a good inducibility of
Gfp in ES cells and particularly in hematopoietic cells after
vavCre mediated activation of the transgene. In this case, the
expression results in a shift of three log units in flow cytometry,
and can be further enhanced to a shift over four logarithmic
units by crossing the transgene to homozygosity. This
expression is very likely to be higher than the levels achieved
Figure 6.  No relevant alterations in the adult cerebellum as a result of RNAi activation in the early cerebellar
primordium.  (A-B) Low magnification DAPI stainings of postnatal day 60 cerebella. Normal lobulation in the RNAi-expressing
cerebellum (Ebf2Cre::Rosa26RNAi/+, panel B), compared to a Cre- control (A). (C-D) Sagittal sections of adult cerebella stained for the
Purkinje cell (PC)-specific marker calbindin (CaBP, red) and for Gfp. RNAi-expressing PCs (Gfp+, panel D) develop normal somata
and dendritic arbors positive for CaBP. Panel E (normal control) shows sagittally sectioned CaBP+ PCs from an
Ebf2Cre::Rosa26YFP/YFP mouse. Size bars: B, 200 µm; E, 25 µm.
doi: 10.1371/journal.pone.0080312.g006
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Figure 7.  Expression levels of Gfp and transgene correlate, but do not influence Ebf protein.  (A) Bone marrow cells from
mice with the indicated genotypes were sorted as negative (G1), low (G2), middle (G3) and high (G4) for the expression of Gfp. (B)
Cells sorted according to the gates in (A) were analysed for the expression of the miRNA by qPCR. Additionally, bone marrow was
isolated from control mice as indicated and used in this analysis. n=3-4; error bars=SD, ** p<0.01, *** p<0.001. (C) Cells sorted
according to the gates in (A) were analysed for the presence of Ebf1 protein by western blot. β-actin is used as loading control and
the genotypes of the donor mice are indicated. For western blot, three biological replicates were pooled and analysed together.
doi: 10.1371/journal.pone.0080312.g007
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using the tet-transactivator to down-regulate p53 [52].
Therefore, and as Ebf genes are not expressed at very high
levels (own unpublished data), we consider it very unlikely that
too low expression of the transgene is the reason for the lack of
down-regulation of Ebf proteins. The expression of the
transgene at different levels allowed us to study a potential
influence on Ebf protein levels closer. The analysis of cells
expressing GFP not at all, or at low, middle or high levels
shows that the transgene encoding is detectable at
corresponding levels, which is not surprising, given that both
are encoded by one mRNA. This also shows that the transgene
encoding for the miRNA sequences is really present in the
transgene. However, no changes in Ebf protein level can be
detected, not even in the highest expressing cells, ruling out
that a potential effect is masked in the bulk analysis of Gfp-
positive cells and showing that the observed expression levels
alone do not explain the lack of down-regulation. Furthermore,
a higher expression of the transgene in homozygous
transgenic animals, but no down-regulation of Ebf proteins in
these mice argues against a dose-dependent effect.In addition,
we conclude that expression of the transgene from the CAG
promotor does not saturate the miRNA/shRNA machinery, as
miRNAs control many aspects of the development of
hematopoietic cells, but we do not observe any phenotypic
changes [35].
A second possibility might be problems with the processing
of a complex polycistronic mRNA in vivo. To generate the
knock-in mice, we used exactly the same DNA construct as in
the retroviral vector used for the infection of cultured murine
and human cells. Therefore, since cells of the same species
were used, differences in the processing machinery between
cultures cells and transgenic mice seem rather unlikely.
Additionally many studies show that the basic RNAi machinery
is ubiquitously expressed. The second possibility is that the
basic machinery is the same in vitro and in vivo, but the
artificial RNAi construct generated poses more problems in its
correct processing than endogenous miRNAs. Chaining of
more than three shRNA sequences strongly decreases the
efficiency in mediating down-regulation for each shRNA and
the expression of Gfp is attenuated by shRNA chaining,
presumably due to increased processing (data not shown).
Together, this might indicate that the construct is on the border
of loosing its effectiveness due to its complexity. Again, the
expression of Gfp in vitro and in vivo and the down-regulation
of Ebf proteins in cultured cells argues against this possibility,
although we consider it more likely than the two afore
mentioned possibilities.
A third general possibility is the design and efficiency of the
RNAi sequences used to inhibit the Ebf proteins. The precise
sequence requirements for efficient RNAi are not well
understood [59], although it is known that thermodynamic
asymmetry, low G/C content and a strong bias for A/U at the 5'
end of the guide strand are important [60–62]. We have tested
the RNAi sequences for down-regulation in cultured cells by
transfection of the shRNA encoding plasmid and by retroviral
infection of primary cells for efficient down-regulation of
transfected and endogenous Ebf proteins [24]. In both cases
however, the RNAi transcripts result from a multitude to several
origins of expression (plasmids / retroviral integration sites), but
not from a single genomic locus as is the case in the transgenic
mice. In fact it is this aspect where the biggest differences
between the in vitro and in vivo approach occur. Based on a
large scale approach, it has been estimated that only 3% of all
possible RNAi sequences for a particular gene elicit efficient
knockdown at the level of single copies [28]. Of all the possible
explanations mentioned here, we consider problems with the
design and the efficiency of the RNAi sequences as single
genomic copies most likely to explain the discrepancy between
in vitro and in vivo, i. e. the absence of a detectable down-
regulation of Ebf proteins.
In summary, we have used a new miR155-based system to
explore the potential to knockdown the expression of several
genes simultaneously. This approach was successfully in vitro,
however, its direct translation in vivo did not result in the
expected down-regulation. We think that the most likely
explanation for this discrepancy lies in the efficiency of the
RNAi sequences as single genomic copies. This, together with
the complexity of the whole RNAi transcript, consisting of three
short hairpins and Gfp, likely results in an overall efficiency that
is too low to detect and that potentially can be compensated
for. We do not think that the overall expression or differences in
the endogenous basic miRNA/RNAi machinery are likely
explanations. The data presented here clearly show that
expression of the transgene from the CAG promoter is
compatible with a normal function of the basal miRNA/RNAi
machinery in hematopoietic cells, and the miR155 framework
works well in the context of inducible expression from the
Rosa26 locus as shown by Gfp. The data presented here
provide the foundation for future work on the simultaneous
knockdown of several genes in vivo, as the problems
concerning the efficiency of the RNAi sequences can be
overcome [59].
Experimental Procedures
Generation of transgenic mice
Two different sequences to inhibit Ebf1, Ebf2 and Ebf3
(RNAi-a and RNAi-b) were excised together with EmGFP from
the pcDNA6.2-GW/EmGFP vector (Invitrogen, [24]), and
inserted into the XbaI site of the pRTS targeting vector (kindly
provided by D. Calado, Immune Disease Institute Inc., Boston,
MA). Mouse ES cells derived from C57Bl/6 x 129S6/SvEvTac-
F1 strains (IDG3.2) were electroporated with this construct and
colonies were isolated in the presence of 170 µg/ml G418
(Gibco). DNA extraction and Southern Blots were performed as
described [63]. The correct insertion of the targeting sequences
was analysed using an external 550 bp 5' probe and an internal
Gfp probe of 723 bp. The 5' probe was cut from the
pRosa26-5-pBS KS plasmid using EcoRI and PacI, the Gfp
probe was isolated from the pcDNA6.2-GW/EmGFP vector
using DraI. Hybridisation was carried out for 16 hours at 65°C
in Church buffer (0.4 M Na2HPO4), membranes were washed 3
x 10 min at 58°C in wash buffer (0.2 x SSC, 0.5% SDS) and
bands were detected using a phospoimager (Fuji Bas 1000).
Two correctly targeted clones representing RNA-a and RNA-b
constructs were injected into C57BL/6 blastocysts that were
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implanted into pseudopregnant females. Chimeric mice were
bred to obtain germ-line transmission. Two male chimera
(80%) corresponding to the RNA-a clone were selected to get
heterozygous mice. Mutant mice were backcrossed with
C57Bl/6 wild-type mice for more than 6 generations. All
experiments involving animals were designed in agreement
with the stipulations of the San Raffaele Institutional Animal
Care and Use Committee, the Helmholtz Zentrum München
and the Regierung von Oberbayern. The protocol and all
experiments involving animals was approved by the ethics
committees of the afore mentioned institutions. All efforts were
made to minimise animal suffering.
Genotyping
For genotyping of mice tails were digested for at least 1 h in
lysis buffer [FirePol buffer B (Solis BioDyne), 1.25 mM MgCl2,
50 µg/ml proteinase K] at 55 °C and inactivated for 15 min at
95 °C. PCR was carried out with genomic DNA; 20 pmol of
each primer were used, for the miRNA line (5'-Rosa fwd 5-
´GAGTTCTCTGCTGCCTCCTG-3´, CAG rev 5´-
TGAACTAATGACCCCGTAATTG-3´, 3'Rosa rev 5´-
AGGAAAGGGAAAATGCCAAT-3´ using FirePol (Solis
BioDyne) under these conditions: 31 cycles of 94 °C for 45 sec,
60 °C for 45 sec, 72 °C for 1 min to amplify products of 600 bp
for wild-type and 290 bp for the mutant allele; for R26RYFP line
(R523 5’-GGAGCGGGAGAAATGGATAT-3’, R26F2: 5’-
AAAGTCGCTCTGAGTTGTTAT-3’, oIMR 316 5’
AAGACCGCGAAGAGTTTGTC-3’) under these conditions: 35
cycles of 94 °C for 30 sec, 58 °C for 1 min, 72 °C for 1 min to
amplify products of 600 bp for wild-type and 320 bp for the
knock-in allele; for Ebf2GFPiCre line (F 5’-
ATGGTGCCAAGGATGACTC-3´, R 5’-
CCTCGAGCAGCCTCACCA-3´) under these conditions: 30
cycles of 94 °C for 30 sec, 58 °C for 30 sec, 72 °C for 30 sec to
amplify a 200 bp product corresponding to the transgene.
Cell-culture, Transfections, Plasmids
HEK293T cells were kept under standard conditions in
DMEM medium (+ 10% FCS, 1% Pen/Str/Glu; Gibco), and
transfected using polyethylenimine (Gibco) according to
standard protocols. For ectopic expression Ebf1, Ebf2 and Ebf3
were cloned into the pcDNA3.1 vector (Invitrogen) in frame with
an N-terminal Flag-tag (Sigma).
Flow cytometry, Antibodies
For flow cytometry single cell suspensions were prepared by
trypsinising ES cells or by aspirating bone marrow according to
standard procedures. Isolated cells were blocked for unspecific
binding using CD16/32 and incubated with either biotinylated or
directly fluorochrome-conjugated antibodies. Cells were
measured or sorted using either an LSRFortessa or a
FACSAriaIII (BD Biosciences) and data were analysed using
FACSDiva (Becton Dickinson GmbH) and FlowJo 9.3 (Treestar
Inc.) software. For depletion of dead cells propidium iodide was
used. Antibodies directed against the following markers were
obtained from BD Biosciences: B220 (RA3-6B2) and CD43
(RM4-5), BP-1 (6C3), CD24 (30-F1), CD16/32 (=FcγRII/III;
2.4G2).
Isolation of RNA and Quantitative RT-PCR
mRNA was isolated using peqGOLD TriFastTM (Peqlab)
according to manufacturer’s instructions, cDNA was
synthesised using SuperScript II reverse transcriptase
(Invitrogen) and the oligo-dT primer (Roche). qPCR reactions
were performed in duplicate with SYBR Green I Master in a
LightCycler® 480II (Roche) with standard conditions: 95 °C for
10 min followed by 45 cycles of 95 °C for 10 s, 65 °C for 10 s
and 72 °C for 10 s. Primer sequences: Hprt fwd 5´-tgc tgg tga
aaa gga cct ctc g-3´, rev 5´-tct ggg gac gca gca act ga-3´; β-
Actin fwd 5'-tgt ggt ggt gaa gct gta gc-3', rev 5'-gac gac atg gag
aag atc tgg-3'; Ebf1 fwd 5´-ggg gac agt gca gat ggt aa-3´, rev 5
´-caa ctc act cca gac cag ca-3´; Gfp fwd 5'-acc tac ggc gtg cag
tgc ttc agc-3', rev 5'-gtc ctc gat gtt gtg gcg gat ctt g-3'; miRNA-
fwd: 5'-ggc atg gac gag ctg tac aa-3', miRNA-rev3: ctc tag atc
aac cac ttt gt-3'. Three independent measurements were
performed for each qPCR analysis, error bars represent the
standard deviation of the mean. The comparative CT method
was used to calculate the expression levels of RNA transcripts,
and the quantified individual RNA expression levels were
normalised for the respective β-actin expression levels, unless
stated otherwise. Since we measured the relative RNA
expression levels, the indicated expression levels were set as 1
or 100.
Histological procedures
Postnatal mice were anaesthetised with Avertin (Sigma, St
Louis, MO, USA) and perfused with 0.9% NaCl followed by 4%
paraformaldehyde (PFA). Tissues were fixed with 4% PFA,
cryoprotected in 30% sucrose overnight, embedded in OCT
(Bioptica), sectioned on a cryotome (18 μm). Cryosections
were immunostained with the following antibodies: rabbit or
mouse anti-calbindin (1:1000, Swant, Bellinzona, Switzerland);
rabbit anti-GFP (1:700; Invitrogen); chicken anti-GFP (1:500;
Abcam, Cambridge, UK).
Statistics
P-values were determined with the Student’s two-tailed t-test
for independent samples, assuming equal variances on all
experimental datasets.
Immunoblotting, Antibodies
Protein isolation and immunoblotting was carried out
according to standard procedures, antibodies used were α-
panEbf [24], α-β-Actin (AC-74, Sigma), α-Flag (M2, Sigma),
The secondary α-mouse-IgG.HRP antibodies were obtained
from Sigma, the secondary α-rat-IgG + IgM.HRP antibody was
purchased from Jackson Immuno Research. Bands in western
blot experiments were quantified using the open source
software ImageJ (http://rsb.info.nih.gov/ij/; W. S. Rasband, NIH,
National Institutes of Health, Bethesda, MD).
Supporting Information
Figure S1.  Schematic overview of the DNA sequences
used for RNAi. (A) The structure of the transcripts of Ebf1,
Ebf2 and Ebf3 is depicted including 5'- and 3'-UTR. Protein
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domains encoded by the transcripts are indicated above (HLH
= helix-loop-helix domain) and the beginning and end of the
coding sequence are given underneath in base pairs relative to
the start site. The sequences used to inhibit the individual
members and their positions are plotted against the transcripts.
Two sequences are indicated for each gene, as two different
RNAi constructs have been generated, and their identifying
numbers are given underneath. (B) Schematic representation
of the organisation of the RNAi used for the transgene. Grey
boxes represent the flanking region from miR155, and the
numbers within the loops indicate the Ebf gene against which
the sequences at this position are directed. The composition of
the two constructs used for RNAi is given below.
(TIF)
Figure S2.  Down-regulation of Ebf1, Ebf2 and Ebf3 by a
single RNAi construct. To analyse the efficiency and
specificity of bioinformatically predicted sequences to down-
regulate the expression of Ebf1, Ebf2 and Ebf3, HEK293T cells
were transfected with expression plasmids encoding the
individual Ebf proteins together with an N-terminal Flag tag.
Expression vectors containing the shRNA sequences either
alone or in combination were co-transfected, and 48 h after
transfection cells were harvested and analysed by Western
blot. α-Flag antibody was used to detect Ebf expression levels,
and α-actin as loading control. Mock is referring to a co-
transfection of the empty parental vector (pcDNA6.2-GW/
EmGFP), no RNAi leaves out the shRNA containing vectors.
(TIF)
Figure S3.  Analysis of B cell fractions A - C in Rosa26RNAi
transgenic mice. Single cell suspensions from bone marrow of
mice with the indicated genotypes were analysed for the
percentage of early B cell fractions. Cells were stained with
propidium iodide, B220, CD43, and gated for FSC/SSC and as
PI negative, and B220 CD43 double positive. The gating
window and the percentage of cells are shown. Cells were
further stained for BP-1 and HSA/CD24, and analysed for
fractions A -C in detail (Figure 4). Representative examples of
the indicated genotypes are shown. The statistical analysis of
fraction A - C in Figure 4B is referring to this setting.
(TIF)
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Figure S1. 
Schematic overview of the DNA sequences used for RNAi. (A) The 
structure of the transcripts of Ebf1, Ebf2 and Ebf3 is depicted including 5'- and 3'-
UTR. Protein domains encoded by the transcripts are indicated above (HLH = helix-
loop-helix domain) and the beginning and end of the coding sequence are given 
underneath in base pairs relative to the start site. The sequences used to inhibit the 
individual members and their positions are plotted against the transcripts. Two 
sequences are indicated for each gene, as two different RNAi constructs have been 
generated, and their identifying numbers are given underneath. (B) Schematic 
representation of the organisation of the RNAi used for the transgene. Grey boxes 
represent the flanking region from miR155, and the numbers within the loops indicate 
the Ebf gene against which the sequences at this position are directed. The 
composition of the two constructs used for RNAi is given below.  
doi:10.1371/journal.pone.0080312.s001 
 
 
Figure S2. 
Down-regulation of Ebf1, Ebf2 and Ebf3 by a single RNAi construct. To 
analyse the efficiency and specificity of bioinformatically predicted sequences to 
down-regulate the expression of Ebf1, Ebf2 and Ebf3, HEK293T cells were 
transfected with expression plasmids encoding the individual Ebf proteins together 
with an N-terminal Flag tag. Expression vectors containing the shRNA sequences 
either alone or in combination were co-transfected, and 48 h after transfection cells 
were harvested and analysed by Western blot. α-Flag antibody was used to detect 
Ebf expression levels, and α-actin as loading control. Mock is referring to a co-
transfection of the empty parental vector (pcDNA6.2-GW/EmGFP), no RNAi leaves 
out the shRNA containing vectors.  
doi:10.1371/journal.pone.0080312.s002 
 
 
Figure S3. 
Analysis of B cell fractions A - C in Rosa26RNAi transgenic mice. Single 
cell suspensions from bone marrow of mice with the indicated genotypes were 
analysed for the percentage of early B cell fractions. Cells were stained with 
propidium iodide, B220, CD43, and gated for FSC/SSC and as PI negative, and 
B220 CD43 double positive. The gating window and the percentage of cells are 
shown. Cells were further stained for BP-1 and HSA/CD24, and analysed for 
fractions A -C in detail (Figure 4). Representative examples of the indicated 
genotypes are shown. The statistical analysis of fraction A - C in Figure 4B is 
referring to this setting. doi:10.1371/journal.pone.0080312.s003 	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differentiation. However, E-boxes, the cognate binding sites for these transcription factors, are
not restricted to the promoters/enhancers of muscle cell-speciﬁc genes. Thus, the speciﬁcity
in myogenic transcription is poorly deﬁned. Here we describe the transcription factor Ebf3 as
a new determinant of muscle cell-speciﬁc transcription. In the absence of Ebf3 the lung does
not unfold at birth, resulting in respiratory failure and perinatal death. This is due to a
hypercontractile diaphragm with impaired Ca2þ efﬂux-related muscle functions. Expression
of the Ca2þ pump Serca1 (Atp2a1) is downregulated in the absence of Ebf3, and its
transgenic expression rescues this phenotype. Ebf3 binds directly to the promoter of Atp2a1
and synergises with MyoD in the induction of Atp2a1. In skeletal muscle, the homologous
family member Ebf1 is strongly expressed and together with MyoD induces Atp2a1. Thus, Ebf3
is a new regulator of terminal muscle differentiation in the diaphragm, and Ebf factors
cooperate with MyoD in the induction of muscle-speciﬁc genes.
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M
uscle cells in the body of vertebrates specify and
differentiate from mesenchymal progenitor cells in the
somites1. This process is initiated by the combined
action of the transcription factors Pax3 and Pax7 (ref. 2).
Together with the myogenic regulatory factors (MRF) Myf5 and
MyoD they form a regulatory network that is central to all early
muscle cell differentiation3,4. Once immature myoblasts have
formed, they fuse to generate multinucleated mature muscle cells
or myotubes, which constitute the minimal functional unit of all
muscles in the body. The transcription factors Myogenin and
Mrf4 regulate the later steps of differentiation by inﬂuencing the
expression of muscle-speciﬁc genes encoding contractile proteins
in fast and slow twitch ﬁbres4. Contraction of skeletal muscles is
achieved via the inﬂux of Ca2þ into the cytosol and its
interaction with Troponin C, triggering the ATP-dependent
sliding of a-actin and myosin ﬁlaments along each other.
For relaxation, Ca2þ is actively removed from the cytosol
into the sarcoplasmic reticulum by Serca proteins, which are
ATP-dependent Ca2þ -speciﬁc ion pumps5,6.
All MRF proteins bind to E-box sequences that are present in
the enhancers or promoters of genes coding for most muscle
contractile proteins4 and also a great many that are not
related to muscle-speciﬁc genes7. Genome-wide Chromatin
immunoprecipitation (ChIP)-seq analysis revealed that MyoD
binds to a large number of E-boxes including non muscle-speciﬁc
ones8. Therefore, additional transcription factors are required to
regulate MRF speciﬁcity for particular target genes. Mef2 is such
an example, as it binds to sites often present in contractile protein
enhancers and interacts cooperatively with MRFs9,10.
Among the skeletal muscles, the diaphragm is one of the most
essential ones, separating the pleural and abdominal body
cavities. It consists of two different muscles, the crural muscle,
which has a central and dorsal location surrounding the
oesophagus and aorta, and the costal muscle, which connects
the diaphragm’s central tendon to the surrounding ribs. During
embryonic development, muscle progenitor cells migrate from
cervical somites to the pleuroperitoneal folds, transient structures
surrounding the oesophagus11. These are assumed to fuse with
the septum transversum, which is thought to give rise to
the central tendon. Many important aspects of diaphragm
development are still unclear, despite its requirement for the
unfolding of the lung at birth and subsequent respiration12.
The family of early B cell factor (Ebf) genes encodes a highly
homologous group of transcription factors consisting of four
members in mammals. The proteins possess a N-terminal
DNA-binding domain, which also harbours transactivation
potential, followed by an IPT/TIG (immunoglobulin, plexins,
transcription factors-like/transcription factor immunoglobulin)
domain, presumably mediating protein–protein interaction, and
an atypical helix-loop-helix domain required for the formation of
homo- and heterodimers. A transactivation domain (TAD) at the
C terminus mediates activation of Ebf target genes13,14. As all
four proteins share over 90% sequence homology within these
domains, except for the TAD, all Ebf proteins bind to the same
DNA sequence and can act redundantly15–17.
Ebf3 is a member of this protein family that is poorly
characterized compared with other Ebf factors. Originally
identiﬁed in neuronal cells18,19, Ebf3 is important for cell
migration in the developing cortex17 and in the projection of
olfactory neurons to the olfactory bulb16. In Xenopus the
homologue Xebf3 acts as a regulator of neuronal differentiation
downstream of XNeuroD20. Furthermore, Ebf3 has been
implicated as a negative regulator of cell proliferation21. Ectopic
expression suppresses proliferation and induces apoptosis of
tumour cell lines22 and Ebf3 was found to be silenced in
most high-grade brain tumour cases in a genome-wide screen
for tumour suppressors23. Silencing of Ebf3 via promoter
methylation was also observed in gastric cancer, and ectopic
expression induced cell cycle arrest and apoptosis24.
Here, we present evidence that mammalian muscle cells
express Ebf3. Its function is critical in the relaxation of muscle
ﬁbres of the diaphragm and essential to allow respiration
immediately after birth preventing postnatal lethality. Ebf3
synergises with MyoD in directly regulating the expression of a
Ca2þ pump necessary for muscle relaxation. Thereby, Ebf3 is a
new transcription factor involved in the regulation of muscle cell-
speciﬁc transcription.
Results
Expression of Ebf3. To analyse the biological role of Ebf3, we
disrupted its gene locus in murine ES cells. Therefore, a targeting
vector was constructed in which an NLS-lacZ gene and a
PGK::neo cassette, ﬂanked by loxP sites, were cloned in frame
after the translational start codon of Ebf3, replacing the ﬁrst four
exons of Ebf3 (Supplementary Fig. 1A). These exons (represent-
ing the ﬁrst 138 amino acids) encode for essential parts of the
DNA-binding and transactivation domain of Ebf3 (ref. 19). Two
out of 800 clones of mouse embryonic stem cells analysed had
correctly incorporated the targeting construction (clones #1 and
#2; Supplementary Fig. 1B). Analysis of genomic DNA from
E18.5 embryos from heterozygous matings by PCR revealed the
presence of all three possible genotypes (Supplementary Fig. 1C;
primers indicated in Supplementary Fig. 1A). To conﬁrm the
disruption of Ebf3 independently of the genomic status,
semiquantitative RT–PCR was performed, revealing the loss of
the Ebf3 transcript in bones of embryonic day (E)18.5 embryos
(Supplementary Fig. 1D).
As a ﬁrst step in the biological analysis of Ebf3, we determined
its expression during embryonic development. Initial but low
expression of Ebf3 can be detected in the second branchial arch
around E8.5 (Supplementary Fig. 3A). Although somites are
present at this stage, Ebf3 is expressed in these structures only
later, at around E9.0 (Supplementary Fig. 3B). In the following
stages, the expression of Ebf3 becomes more complex with
prominent sites in the midbrain, the branchial arches, the dorsal
root ganglia and the olfactory epithelium (Supplementary Fig. 2).
To analyse the expression of Ebf3 independently, qPCR was
performed on whole wild-type embryos between E7.5 and E18.5
(Supplementary Fig. 3C). In this approach, Ebf3 is ﬁrst detectable
at E9.5, strongly increases at E10.5, and is present throughout
embryonic development thereafter with a pronounced decrease at
E15.5 and E16.5. These results conﬁrm data from EST databases,
which list Ebf3 expression from E9.5 on, and are also in line with
the b-gal staining shown here, with the only exception that the
very ﬁrst expression was probably below the detection limit in the
settings used for qPCR. Furthermore, the data show that the loss
of Ebf3 does not alter overall morphology during embryonic
development (Fig. 1a–c and Supplementary Fig. 2). A more
detailed analysis of tissues and cells in E16.5 embryos reveals
prominent expression of Ebf3 in neuronal structures such as the
midbrain, the cerebellar primordium and the mantle layer of
the spinal cord (Fig. 1b). Strong expression is also observed
in the olfactory epithelium, adipose tissue and at sites of
skeletogenesis such as ribs and vertebrae. Moreover, expression
is seen in developing skeletal muscle tissues like the diaphragm
and in the limbs. Again, no developmental defects were observed
in the absence of Ebf3 (Fig. 1c). Staining of E16.5 wild-type
embryos indicates the speciﬁcity of the observed signals except for
the inner lumen of the duodenum (Fig. 1a). To quantify the
expression of Ebf3 in various tissues, we isolated different organs
of E18.5 embryonic and 3-week-old wild-type mice and analysed
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them by qPCR. Accordingly Ebf3 shows the highest expression in
the diaphragm, followed by bone marrow, brain and skeletal
muscle in the embryo (Fig. 1g). Adult mice express Ebf3 at the
highest levels in skeletal muscle followed by the uterus, eye and
diaphragm. Intermediate expression levels can be detected in the
eye, testis, brain and lymph node, and low expression is seen
in the bone marrow and kidney. No expression of Ebf3 was
detected in the lung, thymus, spleen, liver and heart (Fig. 1g).
As diaphragm showed the highest expression among all organs
and tissues examined, we analysed its expression in further details
using in situ detection of b-galactosidase activity. Ebf3 expression
delineates the diaphragm at E18.5, is expressed in the majority,
but not all cells (Fig. 1e), and is speciﬁc in comparison with wild
type (Fig. 1d). Deletion of one or both alleles of Ebf3 does
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Figure 1 | Expression of Ebf3 at sites of osteogenesis and muscle formation. (a–c) Staining for b-galactosidase in cryosections of E16.5 Ebf3þ /þ
(a), Ebf3þ / (b) and Ebf3 / (c) embryos. Ebf3-b-gal-positive cells can be detected in neuronal, olfactory and adipocytic tissues and at sites of
osteogenesis and muscle formation. Staining in the lumen of the duodenum is background. (d–f) Magniﬁcation of Ebf3-b-gal staining in the area
surrounding parts of the diaphragm in Ebf3þ /þ (d), Ebf3þ / (e) and Ebf3 / (f) embryos as indicated by black boxes in a–c. The diaphragm
in this magniﬁcation is surrounded by the lung and liver tissue as indicated. Bar, 100mm. (g) Quantitative PCR analysis of the expression of Ebf3 in
various tissues of wild-type E18.5 embryos (left) or adult animals (right). The pro-B cell line Ba/F3 was used as a negative control and set to 1. n¼ 3;
error bars¼ s.d. Signiﬁcance is calculated in comparison with BaF/3. **Po0.01, ***Po0.001. (h) Single-cell suspensions from the diaphragm of E18.5
Ebf3þ / embryos were sorted into Ebf3-b-gal-positive and -negative cells and subjected to expression analysis of the indicated marker genes for
slow (MyHC-Ib) and fast (MyHC-IIA, MyHC-IIB, MyHC-IIX/D) twitch muscle types by qPCR. n¼ 3; error bars¼ s.d., *Po0.05 **Po0.01.
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not change overall morphology, but seems to induce a slightly
thickened appearance of the diaphragm (Fig. 1f). The diaphragm
consists of B10% type I (slow twitch) and 90% type II (fast
twitch) ﬁbres, which can be distinguished by the expression of
different isoforms of the myosin heavy chain25,26. Ebf3 is strongly
enriched in cells expressing the type II-associated isoforms
MyHC-IIa, MyHC-IIB and MyHC-IIX/D, whereas the type
I-associated MyHC-Ib prevails in Ebf3-negative cells, indicating
that Ebf3 is preferentially expressed by type II or fast twitch ﬁbres
(Fig. 1h).
Deletion of Ebf3 leads to respiratory failure. Embryonic
development proceeds normally in the absence of Ebf3, and, to
deﬁne the biological role of Ebf3 postnatally, we evaluated gen-
otypes from offspring of heterozygous matings at various time
points after birth. From postnatal day 0.5 (D0.5) on, we could not
detect any Ebf3-deﬁcient mice (Fig. 2a), and therefore analysed
earlier time points observing a normal Mendelian ratio of wild
type, heterozygous and knock-out embryos at E18.5 (Fig. 2a).
This ﬁnding suggests lethality around birth, and indeed a close
observation of animals at birth revealed that pups were born alive,
and Ebf3 / mice were indistinguishable from wild-type and
heterozygous littermates in their overall appearance. However,
immediately after birth, Ebf3-deﬁcient mice displayed gasping
respiration and progressive cyanosis (Fig. 2b), and died within 0.5
to 2 h after birth. Examination of wild-type newborn mice showed
that the lungs are unfolded and have a normal appearance of
alveolar ductal lumens, alveoli and small pulmonary vessels
(Fig. 2c–e, upper row). In contrast, lungs from Ebf3 / mice
have a congested appearance, do not unfold, and in consequence
air-containing passages are not formed as in wild-type lungs
(Fig. 2c–e, lower row). This result suggests that the postnatal
lethality and the cyanotic appearance are very likely due to
respiratory failure caused by an inability to unfold the lung at
birth. However, it seems to be a secondary effect, as Ebf3 is not
expressed in the lung (Fig. 1a–g), the morphology of the compact
lung is normal (Fig. 2c–e, lower row) and unfolding is not a lung-
intrinsic property.
The diaphragm and the rib cage are necessary to support lung
function and breathing, and muscle cells of the diaphragm
strongly express Ebf3 (Fig. 1g). As osteoblastic cells express Ebf3
during in vitro differentiation27, we examined the expression of
Ebf3 in bone and bone marrow in vivo to elucidate its role in
skeletogenesis and bone formation. The bone marrow is a
complex mixture of various cell types, and haematopoietic cells
do not express Ebf3 as shown by Ebf3-b-gal staining
(Supplementary Fig. 5A) or by semiquantitative RT–PCR of
E18.5 fetal liver cells (Supplementary Fig. 5B). As primary
Ebf3-positive mesenchymal cells of the bone marrow express high
levels of Scleraxis, aP2 and Prx1, but no markers of chondrocytes
or mature osteoblasts (Supplementary Fig. 4A), we conclude that
Ebf3 is expressed by immature mesenchymal cells, including
mesenchymal stem cells, skeletal progenitors and adipocytes.
A slight increase in CFU-F numbers, that is, in the frequency of
immature mesenchymal cells of the bone marrow, was observed
(Supplementary Fig. 4B), but loss of Ebf3 has no effect on the
formation of bone and cartilage as exempliﬁed by Alcian blue/
Alizarin red staining of E18.5 embryos (Fig. 2f) or at various other
developmental stages (Supplementary Fig. 4C). In addition,
analysis of calciﬁed mineral bone by von Kossa staining
revealed no differences in the absence of Ebf3 (Supplementary
Fig. 4D). Furthermore, no defects in fetal haematopoiesis were
observed (Supplementary Fig. 5C). In contrast, thickening of
muscle ﬁbres was observed in the diaphragm of Ebf3 /
newborn mice, suggesting that deletion of Ebf3 might cause
defects in muscle function (Fig. 2g,h).
Defects in diaphragm contraction in absence of Ebf3. As the
diaphragm has a central role in facilitating the unfolding of the
lung and supporting breathing after birth28, we followed this
observation closer. Electron microscopy revealed hypercontracted
regions within the diaphragm in the absence of Ebf3 and a
shortening of Z-stacks (Fig. 3A,B). Within these regions,
sarcomere length was reduced 38% from 2.11 mm in wild-type
diaphragm to about 1.34 mm in Ebf3 / newborn mice
(Fig. 3C). The phenotype described so far indicates problems
with the relaxation of muscle cells in the absence of Ebf3. To
study potential defects in muscle function in more detail, we
isolated the diaphragm from Ebf3 wild-type and mutant newborn
animals and analysed their reaction to deﬁned electrical
stimulation. In a ﬁrst set of experiments the diaphragm was
electrically stimulated with a single pulse of 50V for 1ms.
Measurement of the resulting twitch shows that the force
produced by the Ebf3-deﬁcient diaphragm was reduced by a
factor of 18 compared with wild-type levels (Fig. 3D). The total
duration of the contraction in response to a single stimulation
was prolonged 11.6-fold (Fig. 3E). As muscle function normally
involves sustained activation, we also measured the same
parameters during tetanus stimulation of the isolated
diaphragm (50V, 1ms, 120Hz for 500ms; Supplementary
Fig. 6A,B). The force produced in response to tetanus
stimulation was reduced by a factor of 3.6 (Supplementary
Fig. 6A), conﬁrming data from the single stimulation
experiment. Furthermore, the full duration of the contraction
after tetanus stimulation was prolonged 23-fold (Supplementary
Fig. 6B). Taken together, the results indicate a strongly
reduced force produced by the diaphragm in response to
stimulation, which explains the missing expansion of the lung
in Ebf3-deﬁcient mice and the resulting failure of respiration and
cyanotic death. Furthermore, the fact that the muscle can be
stimulated, but the duration of the contraction is strongly
prolonged, suggests an impairment in muscle relaxation after
stimulation.
Ebf3 is required for expression of Atp2a1. To gain an under-
standing of the molecular mechanism behind this deﬁciency,
we analysed the expression of genes implicated in muscle con-
traction and relaxation in the diaphragm of E18.5 wild-type and
Ebf3-deﬁcient mice. The vast majority of these candidate genes
did not show differences in expression in absence of Ebf3
(Fig. 3F). A slight but signiﬁcant decrease was observed with
Mlc1f, Tnni2 and skeletal muscle-speciﬁc a-actin, which are all
required for contraction as well as relaxation. Interestingly, the
expression of Atp2a1, which encodes a sarcoplasmic reticulum
Ca2þ -ATPase required for muscle relaxation, was decreased by a
factor of B10, and Ebf3-deﬁcient mice display an almost exact
phenocopy of the deletion of the Atp2a1 gene29. As not all cells of
the diaphragm express Ebf3 (Fig. 1e,f), we sorted Ebf3-b-gal-
expressing cells from the diaphragm by ﬂow cytometry from
Ebf3þ / and Ebf3 / mice. In heterozygous cells Ebf3 was
detected almost exclusively in the b-gal-positive population,
showing a high level of puriﬁcation by this method (Fig. 3G).
Atp2a1 is a marker for fast twitch muscle cells and was strongly
enriched among the Ebf3-b-gal-positive cells in Ebf3þ /
animals, conﬁrming our previous ﬁnding that Ebf3-expressing
cells constitute most, if not all, fast twitch type muscle cells of the
diaphragm (Fig. 1h). In Ebf3-deﬁcient cells this expression, and
thereby the vast majority of overall Atp2a1 expression, was
reduced to undetectable levels, whereas a minor level among
Ebf3-b-gal-negative cells remained unchanged, indicating a cell-
autonomous defect. As expected, Ebf3 expression was reduced to
background levels in Ebf3-deﬁcient cells (Fig. 3G).
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To evaluate whether compensatory mechanisms are active, or
whether other members of the Atp2a gene family are also
affected by the deletion of Ebf3, we analysed the diaphragms
of E18.5 mice as described29. Loss of Ebf3 reduced not only
Atp2a1a and Atp2a1b, the two isoforms of Atp2a1, but
also Atp2a2 by a factor of 7.5 and its two isoforms Atp2a2a
and Atp2a2b by a factor of 73 and 14, respectively
(Supplementary Fig. 6E). Conversely, Atp2a3, the third gene of
this family, showed a slight but signiﬁcant upregulation in
absence of Ebf3 (Supplementary Fig. 6E). Taken together, loss of
Ebf3 leads to a decrease in the expression of the Atp2a1 and
Atp2a2 genes and their isoforms, whereas Atp2a3 shows a minor
upregulation. The product of the Atp2a1 gene is the Serca1
protein, which has a size of 110 kDa. In Ebf3-deﬁcient
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Figure 2 | Deletion of Ebf3 leads to respiratory failure, postnatal death and alterations in muscle morphology. (a) Frequencies of Ebf3 wild-type
and mutant genotypes before and after birth. No Ebf3-deﬁcient mice can be detected 12 h after birth; E18.5: n¼415, D0.5: n¼ 58. (b) Comparison of
wild-type (left), Ebf3-heterozygous (middle) and Ebf3-deﬁcient (right) newborn mice shortly after birth. Length is indicated in centimetres.
(c–e) Histological analysis of longitudinal sections of the lung of wild-type (upper row) and Ebf3-deﬁcient (lower row) newborn mice stained with
haematoxylin/eosin. d and e are increasing magniﬁcations as indicated by the insets. Bar, c: 200mm; d: 100mm; e: 50mm. (f) Alcian blue/alizarin red
staining of cartilage and bone of wild-type or Ebf3 / skeletons at E18.5. (g,h) Cross-sections of diaphragm muscle ﬁbres of newborn wild-type
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of diaphragm muscle from newborn mice of the indicated genotypes. (D) Measurement of single twitch normalized to the cross-sectional area,
representing muscle force in response to the stimulation. (E) Total duration of muscle contraction after single twitch stimulation. n¼ 5 Ebf3þ /þ ,
n¼ 7 Ebf3þ / , n¼4 Ebf3 / ; error bars¼ s.d.; *Po0.05, **Po0.01, ***Po0.001. (F) Ebf3-b-gal-expressing cells were isolated from the diaphragm
of E18.5 Ebf3þ / embryos by ﬂow cytometry and analysed for the expression of the indicated genes by qPCR. Expression in Ebf3þ / cells was set to 1
and relative expression in Ebf3 / cells is shown. n¼ 3, *Po0.05, **Po0.01. (G) Cells of the diaphragm of E18.5 animals were sorted as positive or
negative for the expression of Ebf3-b-gal and analysed by quantitative PCR for the expression of Ebf3 and Atp2a1. Unsorted cells of wild-type diaphragm
were used as control and set to 1; n¼ 3, *Po0.05, **Po0.01. (H) Representative western blot analysis of Serca1 expression in skeletal muscle (SM)
and diaphragm (D) of E18.5 embryos of the indicated genotypes; n¼ 3. In all PCR experiments, values are normalized to wild-type levels, error bars
represent s.d., and P-values were calculated in comparison to the wild-type control.
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diaphragm, the protein was barely detectable and thus strongly
reduced in comparison with wild-type levels (Fig. 3H).
Quantiﬁcation of the protein levels indicated a reduction of
Serca1 in Ebf3-deﬁcient diaphragm by a factor of 3.2. In contrast,
Serca1 from skeletal muscle did not show a signiﬁcant reduction
in Ebf3 / diaphragm compared with Ebf3þ /þ .
Atp2a1 rescues Ebf3-dependent respiratory failure. Since
Ebf3 / mice phenocopy Atp2a1-deﬁcient mice and the
expression of Atp2a1 is strongly downregulated in the absence of
Ebf3, we wanted to determine the importance of Atp2a1 as a
downstream target of Ebf3. Transgenic animals expressing
Atp2a1 under the control of the skeletal muscle-
speciﬁc skeletal a-actin promoter have been reported30. These
mice show transgenic expression in skeletal muscles including the
diaphragm, but do not have any overt phenotype on their own,
allowing us to genetically assess the biological relevance of
Atp2a1 as an Ebf3 target gene in vivo. Genotyping of litters from
Ebf3þ / /Atp2a1tg double-heterozygous crossings revealed a 50%
distribution of the Atp2a1 transgene as expected (Fig. 4a) from
the breeding scheme (Supplementary Fig. 7). Among the Atp2a1
wild-type animals, the frequency of Ebf3þ /þ , Ebf3þ / and
Ebf3 / corresponds to the frequency observed previously
before and after birth (Fig. 4a, left panel). In the presence of the
Atp2a1 transgene, the ratio of Ebf3 / mice at E18.5
surprisingly is not 12.5% as would be expected as a normal
Mendelian ratio but 3%, indicating either a genetic interference
between Ebf3 and the Atp2a1transgene or a synthetic phenotype
(Fig. 4a, right panel). We killed mice at stages E12.5 to E16.5, but
did not observe a higher percentage of the compound Ebf3 / /
Atp2a1tg genotype, arguing against a synthetic phenotype.
A defect earlier than E12.5 seems highly unlikely as the skeletal
a-actin promoter is not active at these stages. The genomic
insertion locus of the Atp2a1 transgene is unknown, but we think
the most likely explanation for the low frequency is genetic
linkage, that is, the transgene is on the same chromosome as Ebf3.
Strikingly, we observe the same frequency of Ebf3 / /Atp2a1tg
animals at D0.5, clearly distinguishing them from Ebf3 / mice.
Ebf3 / /Atp2a1tg mice do not show any signs of cyanosis
or gasping respiration, but display normal morphology and
movement at D0.5 (Fig. 4b). To determine the level of functional
rescue exactly, we analysed sarcomere length in muscle ﬁbres of
the diaphragm from Ebf3þ /þ /Atp2a1tg and Ebf3 / /Atp2a1tg
mice and found no signiﬁcant difference (Fig. 4c). Furthermore,
we subjected whole diaphragms to deﬁned electrical stimulation
as described for the single deletion of Ebf3. Single twitch
stimulation (50V, 1ms) induced a force from Ebf3-deﬁcient
diaphragms that was comparable to Ebf3-expressing muscle
(Fig. 4d). In addition, the duration of contraction was also
comparable in the diaphragm from Ebf3þ /þ /Atp2a1tg and
Ebf3þ /þ /Atp2a1tg mice (Fig. 4e). The force produced under
tetanus stimulation (50V, 1ms, 120Hz for 500ms) was also
rescued by the transgenic expression of Atp2a1 (Supplementary
Fig. 6C) just as the duration of contraction (Supplementary
Fig. 6D). Therefore, we conclude that Atp2a1 is the critical target
gene downstream of Ebf3 causing the defects in muscle relaxation
and the associated cyanotic appearance and postnatal lethality.
However, the transgenic expression of Atp2a1 did not allow for
prolonged survival of Ebf3-deﬁcient mice. In a time period from
24 h after birth up to 4 days, all double-mutant mice died,
but again did not display a cyanotic appearance (Fig. 4f). As
Ebf3 / /Atp2a1tg mice seemed slightly weaker and less active
over time than their littermates, we determined their weight and
found that the gain in newborn mice, particularly from postnatal
day 3 on, is not achieved by Ebf3 / /Atp2a1tg mice (Fig. 4g).
Taken together, the data show that skeletal muscle-speciﬁc
expression of Atp2a1 rescues the defect in muscle relaxation of
the diaphragm, but is unable to compensate for all defects
associated with loss of Ebf3.
Atp2a1 is a direct target gene of Ebf3. The biological importance
of Atp2a1 downstream of Ebf3 and its downregulation in absence
of this transcription factor prompted us to investigate a potential
direct molecular link. Atp2a1 maps to mouse chromosome 7
(ref. 31), and analysis of DNA sequence upstream of the
transcriptional initiation site32 reveals four potential binding
sites for Ebf proteins in its promoter/enhancer (Fig. 5a). Two of
these possess exactly the same DNA sequence as the Ebf-binding
site in the mb-1 promoter where Ebf1 was ﬁrst identiﬁed33;
therefore, we named them as M1 and M2, and two sites as E1 and
E2, which have the inner palindrome of the ideal consensus site
for Ebf proteins34. Ebf3 bound with high afﬁnity to the M1 and
E2 sites but only weakly to the E1 site as shown by electrophoretic
mobility shift assay (EMSA; Fig. 5b). Ebf3 also bound to the M2
site, but slightly different conditions used for the binding buffer
prevent a direct comparison. The binding is speciﬁc, as single-
nucleotide mutation abolished it (the mutant versions are
indicated in Fig. 5a), and the addition of unlabelled (cold)
oligonucleotides in 10-fold excess also leads to a loss of binding
activity. Furthermore, the binding activity could be super-shifted
by an a-ﬂag antibody, demonstrating complex formation between
Ebf3 and the indicated oligonucleotides (Fig. 5b). ChIP assay
using protein extracts from C2C12 cells expressing ﬂag-tagged
Ebf3 showed binding to sites M1, E2 and M2, but not to E1,
largely corresponding to the data from the EMSA assay (Fig. 5c)
and conﬁrming the binding of Ebf3 to these promoter sites
in vivo. To determine whether Ebf3 can transactivate from the
Atp2a1 promoter via the identiﬁed Ebf3-binding sites, a DNA
fragment containing over 1 kb of its promoter was cloned into a
luciferase reporter construct, and point mutations as indicated in
Fig. 5a were introduced into the Ebf-binding sites either alone or
in combination. Figure 5d shows that Ebf3 can transactivate from
the Atp2a1 promoter fragment 4.2-fold. Mutation of site M2
almost completely abolished transactivation, whereas mutation of
site E1 did not have any inﬂuence. Mutation of site M1 or E2 gave
intermediary results. Therefore, we conclude that site M2, which
is closest to the transcriptional start site, is most important for
transactivation of Atp2a1 by Ebf3, and that sites M1 and E2
contribute to reach full activity. Site E1 seems dispensable as Ebf3
binds with low afﬁnity in EMSA, no binding is detected in ChIP
assay and transactivation is not inﬂuenced by its mutation. In
fact, site E1 or neighbouring sequences might negatively inﬂuence
transactivation, as its deletion together with M1 or E2 results in
diminished loss of transactivation (Fig. 5d). Finally, to determine
whether Ebf3 is not only required but also sufﬁcient for the
expression of Atp2a1, C2C12 cells were transfected with Ebf3 and
cultivated in the presence or absence of horse serum to induce
myoblast differentiation. Within 2 days, horse serum alone did
not induce the expression of Atp2a1 (Fig. 5e). Ebf3 alone also had
no effect, but in combination with horse serum leads to a strong
upregulation of Atp2a1. After 5 days, Ebf3 had again no effect on
the expression of Atp2a1, and horse serum had a small inductive
effect, but together, horse serum and Ebf3 strongly induced the
expression of Atp2a1. These data suggest that Ebf3 alone is not
sufﬁcient to induce the expression of endogenous Atp2a1, but
likely acts in concert with other factors expressed during myoblast
differentiation.
Ebf3 and MyoD synergistically induce expression of Atp2a1.
Other members of the Ebf protein family cooperate with basic
helix-loop-helix transcription factors in the induction of target
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genes, like Ebf1 with E2A in B-cell development35,36. Moreover,
E-boxes, the consensus binding sites for bHLH transcription
factors, are found highly enriched in the vicinity of Ebf-binding
sites37,38. A detailed examination of the Atp2a1 promoter yielded
ﬁve E-boxes within the Atp2a1 promoter fragment (X1–X5,
Fig. 6a). MyoD and Myf5 are two bHLH transcription factors
binding to E-boxes that are important for myogenic
differentiation. ChIP-seq analysis for both factors during
proliferation and differentiation of primary myoblasts has been
reported and reveals that MyoD binds to two sites in the Atp2a1
promoter during myoblast differentiation, whereas Myf5 does not
bind under both conditions39. We examined binding of MyoD to
E-boxes present in the Atp2a1 promoter by ChIP and could
conﬁrm strong binding to site X1 and weaker but sigiﬁcant
binding also to site X5. Also, sites X3 and X4 gave an increased
signal, but the values did not reach statistical signiﬁcance
(Fig. 6b). In contrast to Ebf3, ChIP-grade antibodies speciﬁc for
MyoD are available, allowing us to examine its binding in
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primary diaphragm cells in the presence and absence of Ebf3.
Figure 6c conﬁrms binding of MyoD to sites X1 and X5 under
wild-type conditions and also shows that MyoD can bind to these
sites in the absence of Ebf3. To analyse the functional importance
of these E-boxes, we tested them individually with wild-type or
mutated sequences together with MyoD. Figure 6d shows that
MyoD can transactivate 3.4-fold from the Atp2a1 promoter,
which is comparable to the induction with Ebf3 alone. Mutation
of the individual E-boxes as indicated in Fig. 6a leads to a
reduction in transactivation potential in case of sites X1 and X5 to
2- and 1.8-fold, respectively, whereas sites X2 to X4 have no
inﬂuence. Combining mutations in sites X1 and X5 leads to a
reduction of transactivation to 1.4-fold (Fig. 6d). To test potential
synergistic effects between Ebf3 and MyoD, we combined these
two factors with reporter constructs used before. Together,
these two transcription factors lead to a 24.4-fold induction
of the Atp2a1 promoter, displaying strong synergy in their
transactivation capacity. Mutation of Ebf-binding sites M1 or M2
in this context results in a reduction of transactivation to 7.6-fold
and 4.8-fold, respectively, and in a reduction to 14.5-fold in case
of site E2 (Fig. 6e). E-boxes X1 and X5 are important for
co-transactivation, as their mutation reduces induction to 6.8-fold
and 4.6-fold. Finally, the combination of the two strongest
mutations for each class of transcription factors, M2 and X5,
reduced the combined transactivation potential of Ebf3 and
MyoD to 2.4-fold (Fig. 6e). As Ebf3 alone is not sufﬁcient to
induce the expression of endogenous Atp2a1 in C2C12 cells
within 2 to 5 days, but can do so in combination with horse
serum (Fig. 5f), we tested whether Ebf3 and MyoD together have
this ability. MyoD alone can induce the expression of Atp2a1
3.2-fold and 2.8-fold after 2 and 5 days, whereas expression of
Ebf3 alone does not signiﬁcantly induce Atp2a1. Together,
however, Ebf3 and MyoD have the potential to strongly induce
the expression of Atp2a1 by 74.6-fold and 53.4-fold after 2 and 5
days post-transfection (Fig. 6f). The synergistic activity between
Ebf3 and MyoD prompted us to investigate a potential direct
interaction between these transcription factors. To this end, we
transfected C2C12 cells with tagged versions of both factors,
and tried co-immunoprecipitation under various conditions, but
failed to detect a direct interaction.
Redundancy between Ebf factors in the induction of Atp2a1.
The ﬁnding that deﬁciency for Ebf3 leads to a downregulation of
Serca1 in the diaphragm, but not in skeletal muscle, (Fig. 3h) is
surprising and indicates that either the regulation of Atp2a1
expression is different between these muscle types or that com-
pensation between Ebf proteins is going on. As mentioned in the
introduction, Ebf3 is part of a highly homologous family of
proteins consisting of four members, of which functional
redundancy has already been demonstrated16. To analyse whether
the mechanism described here might be more general and not
restricted to the diaphragm, we isolated RNA from diaphragm
and skeletal muscle of wild-type mice and determined the
expression of all four Ebf genes by qPCR. Ebf3 shows the
strongest expression in the diaphragm, followed by an
approximately threefold lower expression of Ebf1, whereas Ebf2
and Ebf4 are only weakly expressed (Fig. 7a). In contrast, Ebf1 is
the most strongly expressed family member in the skeletal
muscle, Ebf3 is 3.4-fold lower, and Ebf2 and Ebf4 again are only
weakly expressed (Fig. 7b). To determine whether there is
functional redundancy between the individual Ebf factors in the
induction of the Atp2a1 gene, we ﬁrst tested their ability to
transactivate from the Atp2a1 promoter. In reporter assays Ebf1,
Ebf2 and Ebf4 have a transactivation potential that is comparable
to the activity of Ebf3 (Figs 5d and 7c), indicating potential
redundancy between these factors. To test this ability with the
endogenous gene, we ectopically expressed Ebf factors either
alone or in combination with MyoD in C2C12 cells and
determined the expression of endogenous Atp2a1 after 2 days.
Ebf1, Ebf2 and Ebf4 alone can induce the expression of Atp2a1
approximately two- to threefold, again largely recapitulating the
ability of Ebf3 alone. In combination with MyoD, however, all Ebf
factors show a strong synergistic effect, resulting in a 60- to
80-fold induction of Atp2a1 (Fig. 7d). To test these results also
genetically, we examined the expression of Atp2a1 in skeletal
muscle from Ebf1 wild-type and mutant mice. Loss of one allele
of Ebf1 leads to a downregulation of Atp2a1 by 21%, whereas its
complete deletion reduces Atp2a1 by 51% (Fig. 7e), conﬁrming a
more general role for Ebf proteins in its regulation and also
indicating dose-dependency of Ebf factors in the induction of the
Atp2a1 gene.
Taken together, the data show that Ebf3 is necessary for the
relaxation of the diaphragm by binding to three consensus sites in
the promoter/enhancer of the Atp2a1 gene, where it synergises
with MyoD to induce the expression of Serca1, which is necessary
for Ca2þ -uptake into the sarcoplasmic reticulum (Fig. 7f). This
mechanism, however, is not restricted to Ebf3 and the diaphragm
but general in muscle cells as all Ebf factors can synergise
with MyoD and transactivate from the Atp2a1 promoter. An
overlapping, but also distinct expression pattern, between mostly
Ebf1 and Ebf3 in the diaphragm versus the skeletal muscle is
responsible for biological effects.
Discussion
The transcription factor Ebf3 was originally identiﬁed because of
its expression in the olfactory epithelium and neuronal cells18,19,
and Ebf3-deﬁcient mice have defects in olfactory receptor neuron
projection16. However, Ebf3 is also expressed outside of the
neural system and Ebf3 / mice die immediately after birth, but
only very little is known about its role in other tissues. Here, we
identify respiratory failure caused by the inability of the lung to
unfold at birth as the reason for the postnatal death. Multiple
organs might account for such a phenotype, including the lung,
the rib cage and the muscles involved in respiration, that is,
mainly the diaphragm and the heart. Ebf3 is not expressed in the
lung and the heart, and development of the lung, heart and bone
proceeds normally in the absence of Ebf3. However, Ebf3 is
expressed strongly in the diaphragm, suggesting an involvement
of muscle cells in the Ebf3-dependent respiratory failure.
Consistent with this notion, the function of Ebf3-deﬁcient
muscle cells of the diaphragm is impaired, resulting in less
force produced in response to single or persistent stimulation and
prolonged duration of muscle contraction after stimulation. This
phenotype of impaired muscle relaxation is highly reminiscent of
the deletion of Atp2a1, which encodes for a Ca2þ -ATPase that
catalyses the ATP-dependent transport of Ca2þ from the cytosol
to the lumen of the sarcoplasmic reticulum40. Interestingly,
Serca1 is strongly downregulated in the diaphragm but not in
skeletal muscle of Ebf3-deﬁcient mice. Ebf1, a highly homologous
member of this family of transcription factors, is most strongly
expressed in skeletal muscle. Ebf1 can act via the same binding
sites in the Atp2a1 promoter, synergises with MyoD, and loss of
Ebf1 leads to a downregulation of Atp2a1 expression in skeletal
muscle, indicating redundancy between individual Ebf factors.
It is an interesting question why the diaphragm differs in its
expression of Ebf factors from other skeletal muscles, however, as
the promoters of Ebf genes have not been characterized with the
exception of Ebf1, this remains subject for further study. An
important question is also why there is a downregulation of
Atp2a1 in the absence of Ebf3 since Ebf1 is expressed in the
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diaphragm as well and is also able to induce its expression. Ebf
factors have dose-dependent effects in other cellular contexts like
B-cell and neuronal development16,35 and, in fact, deletion of
only one allele of Ebf1 also leads to a slight reduction of Atp2a1
in skeletal muscle. Therefore, dose dependency seems to be
responsible for this effect.
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The large phenotypic overlap between loss of Ebf3 and Atp2a1
is striking and together with its downregulation already indicates
the potential importance of Atp2a1 as a target gene of Ebf3.
The genetic rescue of Ebf3-dependent muscle relaxation and
respiratory failure by ectopic expression of Atp2a1 in vivo
identiﬁes it as the biologically most relevant downstream target of
Ebf3 in the diaphragm. However, Serca1 does not completely
rescue deﬁciency for Ebf3 as mice die within 4 days after birth.
This is likely the result of a complex situation in the compound
Ebf3/Atp2a1 mutant animals. The skeletal a-actin promoter does
not recapitulate the expression pattern of the endogenous Atp2a1
promoter, and in addition the expression of Atp2a2 is strongly
downregulated. We failed to identify Ebf-binding sites in the
promoter/enhancer of the Atp2a2 gene, and ectopic expression of
Ebf3 and MyoD alone or in combination did not alter Atp2a2
expression levels in C2C12 cells. In addition, since Atp2a2 is
expressed in slow twitch ﬁbres, its downregulation seems to be
indirect. As this situation is not only complex, but due to the
expression of the transgene to some degree also artiﬁcial, we
decided not to follow the synthetic phenotype any further.
Therefore, the analysis of the biological role of Ebf3 after birth
awaits the generation of conditional knock-out mice.
Interestingly, many muscle-speciﬁc genes harbour E-boxes in
their promoter, which act as binding sites for MRF proteins4,7.
However, E-boxes are not tissue-speciﬁc as they occur not only in
muscle-speciﬁc genes, but also have a much broader distribution,
and MRF factors bind to many E-boxes in nonmuscle-speciﬁc
promoters8. Consequently, an important question in muscle
development is how speciﬁcity is achieved. A combinatorial
action between MRF and other transcription factors has been
suggested, and a few examples have been identiﬁed10,41. In B-cell
development, Ebf1 acts synergistically with the transcription
factor E47, a product of the E2A gene, which also binds to
E-boxes35. Although no direct interaction could be demonstrated
so far, they cooperate in the induction of B-cell-speciﬁc genes36.
There are several striking parallels to the data presented here, like
the involvement of Ebf factors and E-box binding proteins, direct
binding to neighbouring sites in the promoter, no detectable
physical interaction but cooperation in the induction of the
downstream gene. Furthermore, MyoD can replace products of
the E2A gene in the synergistic induction of the B-cell-speciﬁc
lambda5 gene, demonstrating redundancy between bHLH
transcription factors in the cooperation with Ebf proteins42.
Therefore, synergistic effects between E-box-binding factors and
Ebf proteins seem to be a broader phenomenon and not restricted
to B cells. Consequently, although Ebf3 just as other Ebf factors is
clearly not muscle speciﬁc, it could be part of a transcriptional
module that together mediates muscle-speciﬁc gene expression.
In parallel to the high conservation of Ebf genes at the sequence
level during evolution13,14,43, there seems to be also a
considerable level of conservation of their biological role.
Collier, the only Ebf gene in Drosophila, is expressed by cells
that support immature haemocytes and is necessary to maintain
this pool of progenitor cells44. This is highly reminiscent of Ebf2
and its role in the support of immature haematopoietic stem and
progenitor cells45. Besides the support of haemocytes, collier is
also required for the formation of the dorsal/acute 3 (DA3)
embryonic muscle, which does not develop in its absence46,47.
Together with nautilus, the only homologue of MRF bHLH
factors in Drosophila, collier controls shape and morphology of
the DA3 muscle48. Here we report that Ebf3 is required for the
relaxation of the diaphragm and that it synergises with MyoD in
inducing a critical cell-type speciﬁc gene. To our knowledge this is
the ﬁrst implication of Ebf genes in muscle cell function in
mammals, but the phenotype described here differs considerably
from the loss of collier in Drosophila. Hence, either the
requirement for Ebf factors has changed during evolution or
the expression of other Ebf family members and redundancy
might mask a broader role for this gene family in muscle
development. Indeed, it was recently shown that Ebf proteins
participate in transcriptional regulation of muscle development in
Xenopus49, favouring the second possibility.
In parallel to a strong evolutionary conservation at the
sequence level, there might be also a conservation at the level
of interaction partners like bHLH transcription factors. Although
collier and Ebf3 are required for development and function of a
speciﬁc muscle, such a conservation seems true at the broad
biological level, but not in detailed aspects. The diaphragm is a
derivative of myoblasts from myotomes C3, C4 and C5, which
migrate into the septum transversum, a condensation of
mesenchymal cells pre-ﬁguring large parts of the diaphragm,
where they expand and differentiate. This process is not
homologous to the generation of the DA3 muscle, but it is
tempting to speculate that a conservation in the speciﬁcation of
muscle identity might exist at the molecular level despite different
organ development at the cellular level. Therefore, rather than
postulating a relationship between the DA3 muscle in Drosophila
and the diaphragm in the mouse, it seems more likely that Ebf
factors probably in combination with the E-box-binding MRF
factors form a module in muscle cell differentiation that has been
adopted during evolution.
Brody’s disease is a rare myopathy, characterized by
exercise-induced impairment of skeletal muscle relaxation,
stiffness and cramps, resulting from impaired Ca2þ -uptake and
Ca2þ -ATPase activity50. Mutations of Atp2a1 were found in 50%
of Brody’s patients and are genetically associated with Brody
disease51. The reason for the remaining cases of Brody myopathy
is unclear, as the genomic sequence of Atp2a1 is unchanged.
Among these, cases have been reported in which the expression of
Serca1 is strongly reduced52. As Serca1 is strongly downregulated
and barely detectable in the diaphragm of Ebf3-deﬁcient mice, we
suggest that Ebf3 might be involved in at least a subgroup of the
remaining cases of Brody disease. This might be either via
mutation of Ebf3 itself, but this is the more unlikely possibility as
the broad expression of Ebf3 will probably result in more defects
after birth. Alternatively, binding sites for Ebf proteins might be
mutated, preventing Ebf3 from transactivating from the human
Atp2a1 promoter.
Methods
Generation of mice. Two DNA fragments corresponding to the Ebf3 genomic
region were isolated from a mouse 129/Ola genomic cosmid library. The ﬁrst
fragment (50-region) expanded 4.85 kb from a PmlI site upstream of the Ebf3
coding region to the translation start codon. The second region was a PstI fragment
of 4.6 kb from intron 4 to intron 6. The targeting construct was obtained by cloning
these fragments in the pBluescript KS vector, followed by insertion of an NLS-lacZ
gene and a PGK::Neo cassette ﬂanked by loxP sites between both fragments.
NLS-LacZ was cloned in frame with the Ebf3 translation start codon. Mouse ES
cells were electroporated with this construct, and colonies were isolated in the
presence of 400 mgml 1 G418. For DNA extraction, cells were digested with
100 mgml 1 Proteinase K in the presence of 50mM Tris-HCl pH 7.5, 100mM
NaCl and 10% SDS. DNA was ethanol precipitated and analysed by Southern
Blot53. Two clones (#1 and #2) out of the 800 clones analysed had correctly
incorporated the targeting construct, as established by Southern blot. Both clones
were injected into C57BL/6 blastocysts that were implanted into pseudopregnant
females. Chimeric mice were bred to obtain germline transmission. Two male
chimera (80%) corresponding to clone #1 were selected to get heterozygous mice.
The PGK::Neo cassette was removed by crossing with PGK-Cre transgenic mice54.
Mutant mice were backcrossed with C57Bl/6 wild-type mice for more than 10
generations. All experiments involving animals were designed in agreement with
the stipulations of the animal care committee of the Helmholtz Zentrum Mu¨nchen
and the ‘Regierung von Oberbayern’.
Genotyping. For genotyping of mice tails were digested for at least 1 h in lysis
buffer (FirePol buffer B (Solis BioDyne), 1.25mM MgCl2, 50 mgml 1 proteinase
K) at 55 C and inactivated for 15min at 95 C. PCR was carried out with genomic
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DNA and 20 pmol of each primer (Ebf3 fwd 50-GGGCACACCACAGTCTGTC-30 ,
Ebf3 wt rev 50-GGAGGATATACAGGGTCACAC-30 , Ebf-lacZ rev 50-GCGCCG
GTCACCATTACC-30) using FirePol (Solis BioDyne) under these conditions:
35 cycles of 94 C for 30 s, 61 C for 1min, 72 C for 30 s. Atp2a1-transgenic mice
were obtained from Jeffery Molkentin (University of Cincinnati, USA) and
genotyped as described30.
Isolation of primary cells. Bone marrow cells were isolated as described55. For
isolating bone marrow cells, bones (two tibia and two femurs per mouse) from
embryos at day E18.5, bones were pre-digested in DMEM supplemented with 0.1%
collagenase (Sigma) and 0.2% dispase (Roche) twice for 20min. After washing with
PBS, bones were cut and digested three times as above, and supernatant was
collected. For cell isolation from whole organs, adult or embryonic mice were
killed, organs removed and detached by a 100-mm cell strainer. Diaphragm cells
were digested in DMEM supplemented with 0.2% collagenase for 30min,
fractionated and resuspended.
Electrophysiology and force measurements. Experiments were conducted on
diaphragm muscle strips from newborn mice. The pups were killed by cervical
dislocation and after the laparotomy, the rib cage containing the whole diaphragm
was excised and kept in cold MEM-Glutamax (Gibco) supplemented with fetal
bovine serum for dissection. A strip from the right ventral costal hemi-diaphragm
was excised keeping both insertions from ribs and central tendon intact. The
muscle strips were horizontally mounted in Ringer-Krebs-Henseleit solution
(140mM NaCl, 5mM KCl, 1.2mM KH2PO4, 1.2mM MgCl2, 2mM CaCl2, 20mM
Hepes, 6mM glucose; pH 7.4; osmolarity between 290–315mOsM). At constant
perfusion, the solution was kept at 25 C and bubbled with gas mixture of 95% O2
and 5% CO2. The costal end was held in a stationary end and the central tendon
attached to the force transducer (SI-H Force Transducer, 0–50mN, SI-KG4, WPI).
The optimal length (Lo) was deﬁned as the muscle length at which twitch tension
development was maximal, corresponding to the apex of the length-active tension
curve. Stimulation was applied using a Grass stimulator SD9 (Grass Instruments,
Quincy, MA) via closely ﬂanking platinum wire electrodes. Supramaximal stimu-
lation during single twitch was reached at 50V, with 1ms squared pulse duration.
Duration of tetanus stimulation was set for 500ms. The diaphragm force-frequency
relationship was assessed at supramaximal stimulation by sequential excitation of
muscles at 50V with pulse duration of 1ms at 1, 5, 10, 15, 30, 60, 90, 120, 150 and
180Hz, during 500ms, every 3min. The cross-sectional area (CSA) of the muscle
strip was calculated by dividing the mass of the muscle (without rib bone and
central tendon; mg) by the product of the optimal length (Lo, mm) and muscle
density (1.056 g cm 3). The tension was calculated as force (mN) per CSA (cm2).
The traces were acquired at 4 KB s 1 and analysed using PowerLab and
LabChart 7.0 (AD Instruments, Australia).
Cell Culture. 70Z/3, 18-81 TKþ and Ba/F3 cells were cultured in RPMI 1640,
supplemented with 10% fetal calf serum (FCS; PAA), 1% penicillin and strepto-
mycin, 1% L-glutamine. For 70/Z3 and 18-81 TKþ , 1% sodium pyruvate and
0.003% b-mercaptoethanol was used additionally. For the maintenance of Ba/F3
cells, the culture medium was supplemented in addition with 10% conditioned
medium from WEHI3 cells as a source of IL-3. WEHI-3B and Whitlock-Witte
cultures were propagated in RPMI 1640 supplemented with 10% FCS and 0.0003%
b-mercaptoethanol. Stromal cell lines (2018, AFT024, C2C12, GPþE86, HEK293T)
were grown in Dulbecco’s modiﬁed Eagle medium with Glutamax (DMEM), and
osteoblastic cells (C3H10T½, MC3T3) were cultured in minimum essential
medium (MEMalpha) with in addition supplemented 10% FCS, penicillin and
streptomycin and L-Glutamine. All reagents described were purchased from Gibco
unless stated otherwise. In vitro differentiation assay was performed as described56.
In brief, C2C12 cells were transfected with Ebf3-expressing plasmid, and in vitro
differentiation was initiated by adding 2% horse serum in medium instead of fetal
calf serum for 2 or 5 days.
CFU-F assay. Mouse bone marrow cells were harvested from E18.5 Ebf3þ /þ and
Ebf3 / mice as described above. Cell numbers were determined by using Casy
cell counter (Scha¨rfe Systems). Cells were diluted in mouse Complete MesenCult
Medium (StemCell Technologies), and 10,000 cells were seeded per well in six-well
plates. The cells were cultured at 37 C in 5% CO2 for 10 days without medium
change. The medium was aspirated, and each well was washed twice with PBS
thereafter. Cells were ﬁxed with methanol for 10min at room temperature. The
methanol was removed, and each well was stained with Giemsa Staining Solution
for 10min at room temperature. The staining solution was aspirated and each well
was washed with water for several times to remove unbound stain. The water was
removed and the wells were allowed to air dry. Stained colonies were counted
microscopically.
Electron microscopy. Mice were killed at indicated embryonic days. After ﬁxating
whole mice in ﬁxation buffer (2.5% PFA, 2% glutaraldehyde, So¨rens-buffer
(pH 7.4)) for 1 h, further ﬁxation of single organs was carried out in 2.5%
glutaraldehyde at 4 C. Samples were washed three times with cacodylate buffer
(pH 7.4, Science Services) and ﬁxated in chromosmium acid (1.25% potassium
dichromate (K2Cr2O7; pH 7.2), 1% osmium tetroxide (OsO4), 0.85% NaCl).
After stepwise dehydration, samples were treated with propylenoxide (Merck).
Afterwards, samples were incubated in 1:11-mixture (Epon (246mgml 1
dodecenylsuccinic anhydride (Merck), 326mgml 1 methyl-5-norbornene-1,3-
dicarboxylic anhydride (Roth), 522mgml 1 glyicidyl ether 100 (Epon 812, EMS),
15 ml ml 1 2,4,6-tris-dimethylaminomethyl-phenol (Roth) and propylene oxide
(Merck)). Sections were generated using Leica Ultramicrotome and stained with
haematoxylin/eosin or analysed by using a transmission-electron microscope EM
10 CR (Zeiss).
Haematoxylin/eosin staining. Sections were hydrated and afterwards incubated
for at least 4 h in haematoxylin buffer (0.2 g l 1 sodium iodate, 91.8 g l 1
potassium alum sulphate, 50 g l 1 chloralhydrate, 1 g l 1 citric acid, 1 g l 1
hematoxylin; Merck). Following a washing step with water, sections were stained
for 20 s with Eosin (0.17% acid, 0.58% sodium acetate, 5 g l 1 eosin Y; Merck) and
washed again. For mounting, sections were again stepwise dehydrated, incubated
with xylene and embedded with Eukitt (Kindler).
b-Galactosidase staining. Cryosections or whole embryos were perfused in
phosphate buffer (23mM sodium phosphate monobasic, 77mM sodium phosphate
dibasic, pH 7.3). After ﬁxation (0.2% glutaraldehyde, 0.5mM EGTA (pH 7.3),
2mM magnesium chloride, 94mM sodium phosphate (pH 7.3)), samples
were washed three times in wash buffer (625M magnesium chloride, 0.02%
Nonidet-P40, 97.6mM sodium phosphate, pH 7.3). Staining was carried out in
staining solution (96% wash buffer as mentioned above, 4% di-methyl formamide,
10mgml 1 X-gal (Roche), 2.12mg potassium ferrocyanide, 1.64mg potassium
ferricyanide) for at least 16 h. Samples were washed as above, ﬁxed with 4% PFA,
washed twice in PBS and stepwise dehydrated. After incubation in xylene, sections
could be mounted (DPX Mountant, Fluka). All reagents were obtained from Sigma,
if not otherwise provided. Whole mounts were stained as described above, but were
photographed after ﬁxing and washing steps.
Bone histology. Analysis of bone and cartilage by alcian blue/alizarin red staining
was done as described27. In brief, skin of the embryo was removed and whole
embryo was ﬁxed in 95% ethanol for several days. All internal organs were
removed and skeletal tissue was stained for at least 18 h using alcian blue (90%
ethanol, 20% glacial acetic acid, 0.19mgml 1 alcian blue). After washing twice
with 95% ethanol, embryos were macerated in 2% potassium hydroxide. Next,
embryos were stained with Alizarin Red S in 2% KOH solution. After stepwise
dehydration of the embryo in KOH-glycerine solution, skeleton and cartilage were
analysed. To examine calciﬁed bone matrix, femurs and tibia from embryos were
cryosectioned and stained by von Kossa solution as described27.
Flow cytometry. For ﬂow cytometry, cells were obtained from the diaphragm
or the bone marrow as described above. Isolated cells were incubated with
ﬂuorochrome-conjugated antibodies according to standard procedures, measured
or sorted using either a FACSCalibur or a FACSAriaIII (BD Biosciences), and data
were analysed using CELLQuestPro, FACSDiva Software (Becton Dickinson
GmbH) and FlowJo 9.3 (Treestar) software. For depletion of dead cells propidium
iodide was used. Conjugated antibodies directed against the following markers were
obtained from BD Biosciences: Mac1 (M1/70), Gr1 (RB6-8C5), B220 (RA3-6B2)
and CD43 (RM4-5). Antibody CD45.2 (104) was obtained from eBioscience. All
antibodies were used at a dilution of 1:250. For Ebf3-b-galactosidase detection, cells
were isolated as described above, incubated in 1% FCS and 1mM ﬂuorescein
digalactoside (FDG; Invitrogen) for 75 s at 37 C and resuspended in ice-cold DPBS
thereafter.
Gene expression analysis measurement by qPCR. In brief, mRNA was isolated
from cells, whole organs or embryos using peqGOLD TriFast (Peqlab) according to
manufacturer’s instructions; organs and embryos were dispersed before using an
Ultra Turrax T25 (IKA Labortechnik). cDNA was synthesized with a SuperScript II
reverse transcriptase kit (Invitrogen). PCR reactions were performed in duplicate
with SYBR Green I Master in a LightCycler 480II (Roche) with standard condi-
tions: 95 C for 10min followed by 45 cycles of 95 C for 10 s, 65 C for 10 s and
72 C for 10 s. Alternatively, 40 cycles with an annealing temperature of 63 C were
used. Primer sequences for Atp2a1aþ b, Atp2a 2a, Atp2a 2b, Atp2a 1þ 2, Atp2a 2,
Atp2a 3, Sarcolipin and Phospholamban are described29; sequences for MyHC-Ib,
MyHC-IIA, MyHC-IIB, MyHC-IIX/D are according to57, and all other sequences
are listed in the Supplementary Methods. Target gene expression was normalized
to Hypoxanthine phosphoribosyltransferase (HPRT) expression.
Cloning and site-directed mutagenesis. Ebf3 was inserted into the mammalian
expression vector pCMVcyto using standard methods. CTAP-MyoD was obtained
from Michael Rudnicki (University of Ottawa, Canada) as described39. PCR using
speciﬁc primer for genes or genomic DNA were designed with additional
restriction sites as indicated below with italic letters. Subcloning was done by
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digesting PCR products and relevant vectors with corresponding enzymes for at
least 3 h, puriﬁed by gel extraction kit (Qiagen), and ligated for at least 16 h at
16 C. The QuikChange site-directed mutagenesis kit (Stratagene) was used
according to the manufacturer’s instructions to introduce mutations into
Ebf-binding sequences. Primer sequences to generate point mutations are indicated
with small letters given below; binding site core palindromes are underlined.
Sequencing was done for each construct to exclude errors.
Protein extraction and western blotting. Cells or organs were washed twice in
ice-cold PBS and solubilised in the lysis buffer (50mM Tris (pH 8), 150mM NaCl,
1% NP-40, 1 mgml 1 leupeptin, 1 mgml 1 aprotinin, 100mgml 1 PMSF] using
Ultra Turrax T25. The samples were lysed for 40min on ice. The supernatant
(soluble whole-cell lysate) was fractionated on a 10-12% SDS-polyacrylamide
gel and then transferred onto nitrocellulose membranes (Protran, Whatman).
Membranes were ﬁrst blocked in 5% milk-PBS-Tween and then incubated for 14 h
at 4 C with 5% milk-PBS-Tween containing the ﬁrst antibody in a dilution
recommended by the manufacturer. Membranes were washed three times with
PBS-Tween, incubated with 5% milk-PBS-Tween, containing alkaline phosphatase-
conjugated secondary polyclonal antibody, and then washed as mentioned above.
Signals were detected using detection mixture (0.1M Tris-HCl (pH 8.6),
0.25mgml 1 luminol, 0.11mgml 1 para-hydroxy-conmarin acid, 0.009% H2O2)
and Hyperﬁlm ECL (Amersham). The anti-b-Actin (AC-74), a-Flag (M2; F3165),
a-Serca1 (adult; IIH11) and secondary a-mouse-IgG.HRP antibodies were
obtained from Sigma. The anti-b-Tubulin (5H1) was obtained from BD
Pharmingen and a-Serca1 (embryonic; VE121G9) antibody from Thermo
Scientiﬁc. The secondary a-rat-IgGþ IgM.HRP antibody was purchased from
Jackson Immuno Research. Bands in western blot experiments were quantiﬁed
using the open source software ImageJ (http://rsb.info.nih.gov/ij/; W. S. Rasband,
NIH, National Institutes of Health, Bethesda, MD).
Statistics. P-values were determined with the Student’s two-tailed t-test for
independent samples, assuming equal variances on all experimental data sets.
EMSA. Double-stranded oligonucleotides were annealed in annealing buffer
(10mM Tris/HCl (pH 7.4), 10mM MgCl2, 50mM NaCl) and labelled by ﬁlling up
with Klenow enzyme, [a-P32]-dCTP, and unlabelled dATP, dGTP and dTTP and
puriﬁed using Sephadex G50 columns (Amersham Bioscience). The probes used,
are listed below. Probes with mutations (small letters) in Ebf-binding sites
(underlined) were synthesized as shown in Fig. 6a. EMSA was performed as
following: 5 mg protein extracts from HEK293T cells (as described in protein
extraction) was mixed in either binding buffer 1 (10mM HEPES (pH 7.9), 70mM
KCl, 4% glycerol, 1mM EDTA, 1mM DTT, 1 protease-inhibitor (complete mini
EDTA-free, Roche), 2 ml poly(dIdC) (1mgml 1, Sigma), 2 ml BSA (1mgml 1),
2.5mM MgCl2) or for M2-binding site in binding buffer 2 A(20mM HEPES
(pH 7.9), 75mM NaCl, 1% glycerol, 1 mgml 1 salmon sperm DNA, 2mM DTT,
1 protease-inhibitor (complete mini EDTA-free, Roche), 1 ml poly(dIdC)
(1mgml 1, Sigma) 2 ml BSA (1mgml 1), 2mM MgCl2) with either wild-type or
mutated probe DNA (250 ng ml 1), anti-Flag M2 (F3165; Sigma) antibody or
10-fold concentrated unlabelled probe for competition as indicated. Binding
complexes were fractionated on a 4% polyacrylamide gel. After drying of the gel,
signals were detected using Biomax MS ﬁlms (Kodak).
Chromatin Immunoprecipitation. For ChIP assay, either C2C12 cells were
transiently transfected for 2 days or single-cell suspensions of 10 diaphragms
of Ebf3þ /þ and Ebf3 / mice each were pooled, resuspended in IP-Buffer
(10mM Hepes (pH 7.9), 10mM KCl, 1.5mM MgCl2, 0.34M sucrose, 10% protein
inhibitors (complete mini EDTA-free, Roche) in glycerol, 0.1% Triton X-100)
and partially digested in 1,000U Mnase (NEB) for 2min at 37 C. Mnase was
inactivated by adding 10mM EGTA. Afterwards, 150mM KCl and 0.2%
TritonX-100 were added and immunoprecipitation was performed with
a-Flag-coupled magnetic beads (M2; Sigma) or an a-MyoD speciﬁc antibody
(5.8A, Santa Cruz Biotechnology) for at least 16 h at 4 C under rotation. Then
samples were washed twice with washing buffer A (50mM Hepes (pH 7.9),
140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS)
and twice with washing buffer 2 (washing buffer 1, 500mM NaCl) for 10min.
Precipitated complexes were eluted in elution buffer (50mM Tris (pH 8.0), 1mM
EDTA, 1% SDS), reverse crosslinked by incubation at 65 C for at least 16 h and
puriﬁed using NucleoSpin PCR puriﬁcation kit (Macherey-Nagel). DNA was used
for RT–PCR as indicated above, and oligonucleotides and PCR programme are
listed above. Input samples were ampliﬁed simultaneously to internal controls.
Transient transfections and reporter assay. C2C12 cells were transfected by
Lipofectamine 2000 (Invitrogen) as described in manufacturer’s protocol with a 1:3
ratio of DNA (mg) and Lipofectamine (ml). HEK293T cells were transfected using
polyethylenimine (PEI, 1mgml 1; Sigma) according to the standard conditions
with a 1:1 ratio of DNA (mg) and PEI (ml). For reporter assays, HEK293T cells were
transfected with 5 mg of plasmid DNA (composed of reporter/luciferase
(pCMVcyto), activator (pBLLuc5) and b-Galactosidase (pCMVlacZ) plasmids;
5:10:1). Cells were harvested in 100ml reporter lysis buffer (10% glycerol, 1%
Triton X-100, 2mM EDTA, 25mM Tris (HCl; pH 7.8), 2mM DTT) 48 h post-
transfection. Measurement of luciferase activity was carried out by adding assay
buffer (20mM tricin, 1.07mM magnesium carbonate pentahydrate, 2.67mM
MgSO4, 33.3mM DTT, 0.1mM EDTA, 530 mM ATP, 270 mM acetyl-coenzyme A,
470 mM D( )-luciferin (Roche), pH 5.8) to the sample duplicates at 560 nm in the
micro-plate luminometer OrionII. b-Galactosidase activity was measured at
475 nm after adding ﬁrst assay buffer (1% Tropix GalactonPlus; Applied
Biosystems, 1mM MgCl2, 100mM Na-P pH 8) and 20min later activation
buffer (0.2M NaOH; 10% Tropix Emerald Enhancer; Applied Biosystems).
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SUPPLEMENTARY FIGURES 
 
 
Supplementary Figure 1 Generation of Ebf3-Deficient Mice. (A) Schematic representation of 
Ebf3 wild-type (Ebf3+) and mutant (Ebf3­) alleles. A solid line represents regions involved in the 
targeting construct, while a dashed line depicts genomic regions beyond the targeting construct. 
The targeting strategy consists of replacing Ebf3 genomic DNA from the translation start codon to 
a PstI site in intron 4, corresponding to part of the DNA binding domain, by an in frame NLS­Lac0 
gene followed by a PG233Neo cassette flanked by loxP sites indicated by two arrowheads. Boxes 
in the schema represent exons. The white box corresponds to the 5’ untranslated region, while 
black boxes indicate coding regions. Southern blot probes corresponding to 5’ and 3’ regions, and 
to a fragment of the PG233Neo cassette are shown. Small arrows with numbers 1-3 indicate the 
position of primers used for genotyping. The lower two panels represent the Ebf3 locus after 
recombination with the targeting vector (Ebf3neo) and after removal of the PG233Neo cassette via 
PGK-Cre mediated recombination (Ebf3­). (B) Southern blot using 5´probe (left), 3´probe (middle) 
and PG233Neo probe (right) as indicated in A with genomic DNA of wild-type and two mutant ES 
cell clones after EcoRI digestion. (C) Example of genotyping genomic DNA from tails of wild-type 
(+/+), Ebf3-heterozygous (+/-) and Ebf3-deficient (-/-) mice by PCR using primers 1, 2 and 3 as 
indicated in A. No template is used as negative control. (D) Expression of Ebf3 is analysed in 
bones of E18.5 mice of the indicated genotypes (see above) by RT-PCR using 27 cycles.  
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Supplementary Figure 2 Expression of Ebf3 During Embryogenesis. Whole-mount Ebf3-ß-
galactosidase staining of wild-type (left row), Ebf3+/­ (middle row) and Ebf3­/­ (right row) embryos 
from E9.5 to E12.5 as indicated. 
Jin et al., Supplementary Fig. 2
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Supplementary Figure 3  Embryonic and Cell Type Specific Expression of Ebf3. (A-B) Whole 
mount ß-gal staining of Ebf3+/­ embryos at E8.0 to 8.5 (A) and E8.5 to 9.0 (B). Somites are 
indicated by an arrowhead, branchial arches by an arrow. (C) Quantitative PCR analysis of the 
expression of Ebf3 in whole embryos from E7.5 to E18.5 as indicated. The pro-B cell line Ba/F3 
were used as a negative control and set to 1. n=3; error bars=SD; * p<0.05, ** p<0.01, *** p<0.001.  
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Supplementary Figure 4  Ebf3 is Expressed by Immature Mesenchymal Cells, but is not 
Required for Normal Bone Formation. (A) Ebf3-β-gal expressing and non-expressing cells were 
sorted from the bone marrow of E18.5 Ebf3+/­ embryos and subjected to qPCR analysis. Marker 
genes for different developmental stages of various mesenchymal cell lineages are indicated. The 
fold change in the expression between Ebf3-β-gal positive and Ebf3-β-gal negative cells is shown. 
n=5, error bars=SD. * p<0.05, ** p<0.01, *** p<0.001. (B) Determination of CFU-F frequency from 
the bone marrow of E18.5 Ebf3+/+ and Ebf3­/­ mice. n=3 (Ebf3­/­) to 4 (Ebf3+/+); error bars=SD; 
***p<0.001. (C) Alcian blue / alizarin red staining of cartilage and bone of wild-type or Ebf3­/­ 
skeletons at E14.5 and E16.5. (D) Von Kossa and nuclear fast red staining of longitudinal sections 
of tibia and femur of Ebf3+/+ and Ebf3­/­ embryos from E16.5 to D0.5 as indicated.  
 Supplementary Figure 5 Ebf3 is Not Expressed in the Fetal Liver and is Not Required for 
Normal Embryonic Hematopoiesis. (A) Analysis of fetal liver cells from E18.5 Ebf3+/+, Ebf3+/­ and 
Ebf3­/­ embryos for the expression of Ebf3-β-gal and CD45.2 by flow cytometry. n=5. (B) Semi-
quantitative RT-PCR for the expression of Ebf3 in liver and brain of wild-type E18.5 embryos. 
Primers specific for β-actin are used as control. n=3. (C) Representative examples of fetal liver 
cells analysed by flow cytometry for the percentage of B220/CD43 and Mac1/Gr1 from E18.5 wild-
type and Ebf3­/­ embryos. n=3. 
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Supplementary Figure 6 (A-D) Tetanus stimulation (50V, 1ms, 120 Hz for 500ms) of 
diaphragm muscle from newborn mice of the indicated genotypes. (A) Measurement of force 
produced in response to tetanus stimulation normalised to the cross sectional area. (B) Total 
duration of muscle contraction after tetanus stimulation. n=5 Ebf3+/+, n=7 Ebf3+/­, n=4 Ebf3­/­; error 
bars = SD; * p<0.05, ** p<0.01, *** p<0.001. (C) Measurement of force produced in response to 
tetanus stimulation normalised to the cross sectional area. (D) Total duration of muscle contraction 
after tetanus stimulation. n=3; error bars = SD. (E) Analysis of the expression of various splice 
variants of the Atp2a1, Atp2a2 and Atp2a3 genes in E18.5 embryonic diaphragm of the indicated 
genotypes; n=3, *p<0.05, **p<0.01. 
 
 
 
 
Supplementary Figure 7 Indication of the breeding scheme used to generate Ebf3/Atp2a1 
double mutant mice. A breeding scheme involving three generations was followed (G0-G2), in 
which the mating of Ebf3+/­ to Ebf3+/­/Atp2a1tg mice in G1 results in a 50% distribution of the Atp2a1 
transgene in G2. Within these 50%, a Mendelian distribution of the wild-type and the mutant Ebf3 
allele should be observed in case Ebf3 and the Atp2a1 transgene segregate independently of each 
other. The expected frequencies for independent segregation are indicated.
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SUPPLEMENTARY METHODS 
 
Primers used in Gene Expression Analysis Measurement by IPCR 
Hprt fwd 5´-TGCTGGTGAAAAGGACCTCTCG-3´ 
Hprt rev 5´-TCTGGGGACGCAGCAACTGA-3´ 
Ebf3 fwd 5´-AGAGCCGAACAACGAGAAAA-3´ 
Ebf3 rev 5´-GCACATCTCCGGATTCTTGT-3´ 
Atp2a1 fwd 5´-ACACAGACCCTGTCCCTGAC-3´ 
Atp2a1 rev 5´-TGCAGTGGAGTCTTGTCCTG-3´ 
Prx1 fwd 5´-AGGCCAGAGTGCAGGTGTGGT-3´ 
Prx1 rev 5´-TGGATGGCTGGGGAGCGTGT-3´ 
Scx fwd 5´-CTGTGGCGACGGGCAACCAT-3´ 
Scx rev 5´-GGCCTGGGTCAGTGTTCGGC-3´ 
Dermo1 fwd 5´-CAGCGCACCCAGTCGCTCAA-3´ 
Dermo1 rev 5´-CAGGTGGGTCCTGGCTTGCG-3´ 
aP2 fwd 5´-GAAGTGGGAGTGGGCTTTGCCA-3´ 
aP2 rev 5´-GGGCCCCGCCATCTAGGGTT-3´ 
Adiponectin fwd 5´-CACACCAGGCCGTGATGGCA-3´ 
Adiponectin rev 5´-CGGGTCTCCAGCCCCACACT-3´ 
Pref­1 fwd 5´-CCATCGTGCGCAGAAGCCCA-3´ 
Pref­1 rev 5´-GCCGAAAGCCAGCAGGAGCA-3´ 
Col10a1 fwd 5´-ACCCCAAGGACCTAAAGGAA-3´ 
Col10a1 rev 5´-CCCCAGGATACCCTGTTTTT-3´ 
PPAR­gamma fwd 5´-GATGGAAGACCACTCGCATT-3´ 
PPAR­gamma rev 5´-GGATCCGGCAGTTAAGATCA-3´ 
Col1a1 fwd 5´-CACCCTCAAGAGCCTGAGTC-3´ 
Col1a1 rev 5´-GTTCGGGCTGATGTACCAGT-3´ 
Runx2 fwd 5'-TTTAGGGCGCATTCCTCATC-3' 
Runx2 rev 5'-TGTCCTTGTGGATTAAAAGGACTTG-3' 
Osx fwd 5'-ACTCATCCCTATGGCTCGTG-3' 
Osx rev 5'-GGTAGGGAGCTGGGTTAAGG-3' 
AP fwd 5'-CACGCGATGCAACACCACTCAGG-3' 
AP rev 5'-GCATGTCCCCGGGCTCAAAGA-3' 
Ocn fwd 5'-ACCCTGGCTGCGCTCTGTCTCT-3' 
Ocn rev 5'-GATGCGTTTGTAGGCGGTCTTCA-3' 
Bsp fwd 5'-TACCGGCCACGCTACTTTCTTTAT-3' 
Bsp rev 5'-GACCGCCAGCTCGTTTTCATCC-3' 
Sox9 fwd 5'-CTGAAGGGCTACGACTGGAC-3' 
Sox9 rev 5'-TACTGGTCTGCCAGCTTCCT-3' 
Col2a1 fwd 5'-GCCAAGACCTGAAACTCTGC-3' 
Col2a1 rev 5'-CTTGCCCCACTTACCAGTGT-3' 
!­Actin fwd 5'-GACGACATGGAGAAGATCTGG-3' 
!­Actin rev 5-TGTGGTGGTGAAGCTGTAGC-3' 
ChIP M1 fwd 5´-TGTCCCCTTTTCTCCATACC-3´ 
ChIP M1 rev 5´-CCCAAGCCAGTGACTGAGAG-3´ 
ChIP M2 fwd 5´-TAAGGGCCAAGAGGGCTTAT-3´ 
ChIP M2 rev 5´-CCCAGTTGCCTCAACTTCTC-3´ 
ChIP E1 fwd 5´-TGTTGCATCAGGGTGAGAGT-3´ 
ChIP E1 rev 5´-GCAGGGGGAGTAAGGATCTC-3´ 
ChIP E2 fwd 5´-GACACTAAATCCCTTGTTGATGG-3´ 
ChIP E2 rev 5´-GGGGACAGTGCAGATGGTAA-3´ 
Ebf1 fwd 5´-CATGTCCTGGCAGTCTCTGA-3´ 
Ebf1 rev 5´-CAACTCACTCCAGACCAGCA-3´ 
Ebf2 fwd 5´-TGGAGAATGACAAAGAGCAAG-3´ 
Ebf2 rev 5´-GGGTTTCCCGCTGTTTTCAAA-3´ 
Ebf4 fwd 5´-TTGACTCCATGTCGAAGCAG-3´ 
Ebf4 rev 5´-GCAGTTCTGGTTGCATTTGA-3´ 
Tpm1 fwd  5´-TGAGCAAGCGGAGGCTGATAAG-3´ 
Tpm1 rev  5´-GCATCTTTGAGAGCCTCGGAGT-3´ 
Eno3 fwd  5´-CTGCTCCTGAAGGTCAACCAGA-3´ 
Eno3 rev  5´-GTCAGCGATGAAAGTGTCTTCGG-3´ 
MyBP­C fwd  5´-GAAGGAACTGGTGCCTGACAAC-3´ 
MyBP­C rev  5´-CTGTAGTCAGCCTCATCAGCAG-3´ 
M­cadherin fwd  5´-AGGACGAGCATAGCTGAAGGAG-3´ 
M­cadherin rev  5´-GTCCACTTGCAGCCAGTCTTCT-3´ 
Rbm24 fwd  5´-GTGAATCTGGCATACTTGGGAGC-3´ 
Rbm24 rev  5´-ATGACCACTCCAGGCTGCACAA-3´ 
Tnnc1 fwd  5´-GATGGTTCGGTGCATGAAGGAC-3´ 
Tnnc1 rev  5´-CTTCCGTAATGGTCTCACCTGTG-3´ 
MyHC­EMB fwd  5´-CTGGCTAAGTCGGAGGCAAAGA-3´ 
MyHC­EMB rev  5´-TCGCATCGTTCCTCAGCATCCA-3´ 
MyHC­PN fwd  5´-GGAGGACAAAGTCAACACCCTG-3´ 
MyHC­PN rev  5´-CCTCCAGTTTCCTCTTGGCTCT-3´ 
Mlc1f fwd  5´-TTCGTTGAGGGTCTGCGTGTCT-3´ 
Mlc1f rev  5´-CAGCAACGCTTCTACCTCTTCC-3´ 
Tnni2 fwd  5´-GGCTCTAAGCACAAGGTGTGCA-3´ 
Tnni2 rev  5´-ATTCTTCCTCCAGTCACCCACG-3´ 
skeletal )­actin fwd  5´-ACCATCGGCAATGAGCGTTTCC-3´ 
skeletal )­actin rev  5´-GCTGTTGTAGGTGGTCTCATGG-3´ 
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Primers used for cloning and site­directed mutagenesis 
Ebf3 Luc fwd 5´-GTCGACATGTTTGGGATTCAGGAGAA-3´ 
Ebf3 Luc rev 5´-CTCGAGTCACATGGGCGGGAC-3´ 
Atp2a1pr.1 fwd 5´-AAGCTTGTGCTCTTTGCTCCCAACTC-3´ 
Atp2a1pr.1 rev 5´-GGATCCGACCCCAGTCCTACTTGCGC-3´ 
∆M1 fwd 5´-GCTTCATCCAGCCTCAGccGTCCTGCTCTCAG-3´ 
∆M1 rev 5´-CTGAGAGCAGGACggCTGAGGCTGGATGAAGC-3´ 
∆M2 fwd 5´-TGGAAAGATCTGCTCAGccGTGGGCTTGGAACTG-3´ 
∆M2 rev 5´-CAGTTCCAAGCCCACggCTGAGCAGATCTTTCCA-3´ 
∆E1 fwd 5´-GGGGGTCACCATGAAGaatTAGGGTTGAAGGCTAGTG-3´ 
∆E1 rev 5´-CACTAGCCTTCAACCCTAattCTTCATGGTGACCCCC-3´ 
∆E2 fwd 5´-GGCTGCAGCAACCCCTaatTAGGGTAAGGTTACCATCTG-3´ 
∆E2 rev 5´-CAGATGGTAACCTTACCCTAattAGGGGTTGCTGCAGCC-3´ 
∆X1 fwd 5´-CCCCGGCTGCTCCTCCTCCAGttacgaCTTGGGTGGAAATCAAAAGATACCCC-3´ 
∆X1 rev 5´-GGGGTATCTTTTGATTTCCACCCAAGtcgtaaCTGGAGGAGGAGCAGCCGGGG-3´ 
∆X2 fwd 5´-GGGTTACCTGGCctatgtaGTGTCCCATTTTC-3´ 
∆X2 rev 5´-GAAAATGGGACACtacatagGCCAGGTAACCC-3´ 
∆X3 fwd 5´-CTAGGGTAAGGTTACaaaaGCACTGTCCCCTTGACT-3´ 
∆X3 rev 5´-GTCAAGGGGACAGTGCttttGGTAAGCTTACCCTAG-3´ 
∆X4 fwd 5´-GGAGAAGTTGAGGttacgaGGGGTGGGG-3´ 
∆X4 rev 5´-CCCCACCCCtcgtaaCCTCAACTTCTCC-3´ 
∆X5 fwd 5´-CTCCCTCATAAGGACCaaaaGGGGGCTGGG-3´ 
∆X5 rev 5´-CAGCCCCCttttGGTCCTTATGAGGGAGTG-3´ 
 
Primers used in EMSA 
Atp2a1 M1 fwd 5´-GATGGCTGCCATCCAGCCTCAGGGGTCCTGCTC-3´ 
Atp2a1 M1 rev 5´-CAGTGCAGATGGAGCAGGACCCCTGAGGCTGGATG-3´ 
Atp2a1 ∆M1 fwd 5´-GATGGCTGCCATCCAGCCTCAGccGTCCTGCTC-3´ 
Atp2a1 ∆M1 rev 5´-CAGTGCAGATGGAGCAGGACggCTGAGGCTGGATG-3´ 
Atp2a1 M2 fwd 5´-GATGGCTGCGAAAGATCTGCTCAGGGGTGGGCTTG-3´ 
Atp2a1 M2 rev 5´-CAGTGCAGATGCAAGCCCACCCCTGAGCAGATCTTTTC-3´ 
Atp2a1 ∆M2 fwd 5´-GATGGCTGCGAAAGATCTGCTCAGccGTGGGCTTG-3´ 
Atp2a1 ∆M2 rev 5´-CAGTGCAGATGCAAGCCCACggCTGAGCAGATCTTTTC-3´ 
Atp2a1 E1 fwd 5´-GATGGCTGCCCATGAAGCCCTAGGGTTGAAGG-3´ 
Atp2a1 E1 rev 5´-CAGTGCAGATGCCTTCAACCCTAGGGCTTCATGG-3´ 
Atp2a1 ∆E1 fwd 5´-GATGGCTGCCCATGAAGaatTAGGGTTGAAGG-3´ 
Atp2a1 ∆E1 rev 5´-CAGTGCAGATGCCTTCAACCCTAattCTTCATGG-3´ 
Atp2a1 E2 fwd 5´-GATGGCTGCGCAGCAACCCCTCCCTAGGGTAAGGTTAC-3´ 
Atp2a1 E2 rev 5´-CAGTGCAGATGGTAACCTTACCCTAGGGAGGGGTTGCTGC-3´ 
Atp2a1 ∆E2 fwd 5´-GATGGCTGCGCAGCAACCCCTaatTAGGGTAAGGTTAC-3´ 
Atp2a1 ∆E2 rev 5´-CAGTGCAGATGGTAACCTTACCCTAattAGGGGTTGCTGC-3´ 
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7. Discussion 
 
7.1. Generation of the EbfmiRNA mouse line 
 
Ebf transcription factors are highly homologous and each member’s contribution to a 
biological process is likely compensated for by their co-expression. Therefore, 
genetic redundancy is an important aspect when studying the biological role of single 
Ebf genes (Dubois & Vincent, 2001; Liberg et al., 2002; Wang et al., 2004).  
To overcome a potential redundancy between Ebf factors in the support of 
hematopoietic stem cells, a new RNAi construct was generated with three 
concatemerized shRNA sequences against Ebf1, Ebf2 and Ebf3 incorporated into a 
polycistronic expression vector for RNA polymerase II (Chung et al., 2006; Kieslinger 
et al., 2010). In cultured cells, this RNAi construct shows high efficiency for down-
regulating the targeted Ebf factors simultaneously (Kieslinger et al., 2010). To 
overcome the limitations of cell culture approaches, we wanted to develop the RNAi 
system for use in vivo. 
 
In a newly generated EbfmiRNA transgenic mouse line, the miRNA cassette 
including the Gfp marker gene is inserted into a targeting vector for the Rosa26 locus. 
The Rosa26 locus provides reproducible and ubiquitous transgene expression of 
inserted constructs (Backman et al., 2009; Kleinhammer et al., 2011). It has been 
used to knock-in a variety of transgenes including cDNA, reporters and noncoding 
RNAs without causing phenotypic changes due to the disruption of the Rosa26 locus 
(Casola, 2010).  
Furthermore, the synthetic CAG promoter, which has stronger transcriptional activity 
than the endogenous promoter activity of the Rosa26 locus is used to induce high 
expression of the transgene (Alexopoulou et al., 2008; Niwa et al., 1991). 
Downstream of the CAG promoter, loxP sites flank a transcriptional Stop site and a 
PGK/Neo resistance cassette. The loxP sites are deleted when Cre recombinase is 
expressed, thereby allowing tissue-specific expression of the RNAi construct 
together with Gfp. 
 
Ebf1 is the only Ebf family member expressed in B-lymphocytes and its deletion 
completely blocks early B cell development. Specifically, Ebf1-deficient mice show 
strongly reduced numbers of early B cells (fraction B and C) in the bone marrow (Lin 
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& Grosschedl, 1995; Hardy, 2001; Fig. 8). In case our RNAi construct is effective in 
down-regulating Ebf transcription factors, an inhibition of early B cell differentiation is 
expected upon induction of the transgene. 
 
 
Ebf1+/+                                    Ebf1-/- 
A-C A-C 
B"
A"
 
 
Figure 8. B-lymphocyte differentiation in Ebf1-deficient mice. 
(A) The expression of B220 and CD43 identifies early B-lymphocytes of fraction A-C (orange 
gate). B220+CD43+ cells were further analyzed for the expression of BP-1 and HSA (CD24) 
(B) Fraction A, B and C of pro-B cells are indicated as black, blue and red gate. In both wild-
type and Ebf1-deficient mice, fraction A cells represent as 0.5% and 0.6% of total bone 
marrow cells. Ebf1-dificient mice lack cells in fractions B and C (figure modified from Lin & 
Grosschedl, 1995).  
 
 
Therefore, the hematopoietic system was chosen to test the efficiency of our RNAi 
system in vivo. Additionally, since a precise functioning of the RNAi pathway is 
required for T cell development, we are also able to test the specificity of the 
transgene.  
 
The Vav-iCre mouse line was considered as an ideal way to examine the efficiency 
and specificity of our RNAi system in vivo (Kuhn et al., 1995; de Boer et al., 2003; 
Ventura et al., 2004). The Vav gene is expressed in immature hematopoietic cells, 
including hematopoietic stem cells. Therefore, the Cre-loxP recombination strategy 
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will induce expression of the transgenic RNAi construct and the Gfp marker gene in 
all hematopoietic cells (Ogilvy et al., 1999; de Boer et al., 2003; Fig. 9).  
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Figure 9. Hematopoietic system and Ebf/RNAi test strategy.  
Expression of the Cre recombinase starts in HSC and leads the deletion of the loxP-flanked 
transcriptional Stop site in all hematopoietic cells. Efficiency of the RNAi-based transgene can 
be analyzed in the B-cell linage, as Ebf1 is essential for early B cell development. Also, as T- 
cell development requires a precisely regulated RNAi pathway, specificity of the transgene 
can be tested in this cell lineage. HPC, hematopoietic progenitor cell; CLP, common lymphoid 
progenitor; CMP, common myeloid progenitor (figure modified from Metcalf, 2007). 
 
 
7.2. RNAi and RNA polymerase II driven shRNA 
 
RNAi, mostly by virtue of short-hairpin RNAs (shRNA), has been developed as an 
efficient tool to silence the expression of single target genes for studying specific 
gene function (Kunath et al., 2003; Ventura et al., 2004; Kleinhammer et al., 2011). 
The shRNA includes a short loop of 4-11 nucleotides, forming a hairpin structure and 
can be transcribed using RNA polymerase III (pol III)- or RNA polymerase II (pol II)- 
dependent promoters (Kunath et al., 2003; Ambros et al., 2004). Initially, RNA pol III-
dependent promoters were used for expressing a single shRNA. However, the use of 
RNA pol III has several disadvantages. For example, it lacks the possibility for tissue- 
specific expression, the expression levels cannot be controlled and reporter genes 
cannot be co-transcribed (Yu et al., 2002; Jazag et al., 2005). In fact, most if not all 
miRNA genes are synthesized by RNA pol II (Cai et al., 2004; Lee et al., 2004). Also, 
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the pri-mRNA transcripts, which are generated by RNA pol II, contain poly (A) tails 
and are spliced occasionally (Lee et al., 2004).  
BIC is a murine non-coding RNA that contains the stem-loop miR-155 miRNA 
precursor (Lagos-Quintana et al., 2002). Because the mouse BIC gene is functionally 
efficient to produce the miR-155 precursor in mammalian cells, miR-155/BIC 
represents a good framework for pol II-based RNAi vectors (Chung et al., 2006). 
Importantly, miR-155/BIC has successfully been used to concatermerize several 
sequences with flanking regions that are recognized and cleaved by the RNAse III 
enzyme Drosha (Chung et al., 2006). Therefore, combining the SIBR (synthetic 
inhibitory BIC-derived RNA) vector and the miR-155 based construct was considered 
as a new and promising approach to down regulate three Ebf genes simultaneously 
in vivo.  
 
 
7.3. RNAi expression in vivo 
 
According to direct measurement of Gfp via flow cytometry and deletion of the RNAi 
sequences by qPCR, I confirmed that the expression of our RNAi construct was 
inducible at high levels in hematopoietic cells. However, no significant defects were 
observed in B cell development in vivo such as differences in the percentage of early 
B cells (fraction A-C).  
To explain this discrepancy between in vitro and in vivo experiments with the same 
RNAi constructs, three different possibilities are proposed: The expression level, the 
complexity of the transgene and the efficiency of the RNAi sequences.  
 
Firstly, the expression level of the RNAi construct in vivo has to be considered. To 
achieve a high and stable expression level, the pol II-driven synthetic CAG promoter 
(CMV early enhancer/ chicken β-actin) was chosen. This promoter facilitates long-
term and stronger expression of transgenes compared to CMV and β-actin promoters 
(Alexopoulou et al., 2008). It also allows the co-expression of a marker gene such as 
Gfp. Indeed, I was able to demonstrate that this promoter strongly induces the 
expression of the RNAi construct and Gfp in all hematopoietic cells. 
 
To determine a potential influence of expression levels, we wanted to separate cells 
according to their expression level of the transgene. To this end, I found and isolated 
three distinct population of Gfp-expressing cells from high to low level by flow 
Discussion  Jeehee Kim  	  
	   71	  
cytometry. Together with co-authors, I confirmed the correlation between the 
expression of Gfp and the miRNA construct by qPCR. The expression of Gfp was 
higher in homozygous transgenic mice than homozygous transgenic mice and the 
expression of the transgene corresponds to Gfp. However, both in hetero-, and 
homozygous transgenic mice, the Ebf protein levels in the high, middle or low 
expressing cells were comparable. Therefore, an insufficiency of expression of the 
transgene alone is unlikely to provide an explanation for the discrepancy in the 
effectiveness of the RNAi construct in vivo.   
 
Secondly, the complexity of the polycistronic mRNA sequences may impair their 
processing in vivo. In our group’s previous experiments, the combination of four 
shRNA sequences that target all four Ebf family members resulted in a strongly 
reduced down-regulation efficiency (data now shown). The artificial RNAi constructs 
likely pose more problems of correct processing due to their structural complexity. 
Therefore, it is likely that mir155-based RNAi constructs with three concatemerized 
shRNA sequences reach the maximum level of complexity for processing in the RNAi 
pathway.  
 
Finally, finding the appropriate RNAi sequences is one of the most important 
determinants to generate efficient RNAi constructs in vivo as well as in vitro. The 
RNAi constructs in this study were designed using state-of-the-art computer 
predictions and underwent biochemical testing before the best sequence 
combination against Ebf1, Ebf2, and Ebf3 was selected. These constructs have 
shown a high efficiency in the down-regulation of Ebf1, Ebf2, and Ebf3 in cell culture 
as demonstrated by us and other groups (Kieslinger et al., 2010; Croci et al., 2011; 
Chiara et al., 2012).  
 
However, it was later found that sequences predicted by such computer programs 
work efficiently in only a small percentage in vivo (Dow et al., 2012). In addition, the 
expression of RNAi transcripts is derived from multiple integration sites in cultured 
cells, whereas the transgenic mice express it from a single genomic locus. Therefore, 
it is necessary to consider more carefully this different aspect between in vitro and in 
vivo to design precise RNAi sequences. New methods have been established such 
as the massively parallel sensor assay to develop highly efficient RNAi sequences 
which are also suitable for use in vivo (Fellmann et al., 2011).  
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7.4. Ebf3 in muscle function  
 
Ebf3 has been known as an important regulatory factor in neuronal differentiation 
(Garel et al., 1997; Wang et al., 2004; Chiara et al., 2012). However, the biological 
role of Ebf3 outside of the neuronal system is poorly characterized. Here, in the 
second publication (Nature Comm., 2014), Ebf3 expression during mouse embryonic 
development was examined, and Ebf3 was identified as an important regulator for 
the function of a specific muscle by analyzing Ebf3-deficient mice.  
 
To generate Ebf3-/- mice, the first four exons (exons 2-5) after the translational start 
site, which encode for essential parts of the DNA binding domain, are replaced by 
the NLS-LacZ gene and a PGK/Neo cassette. Thereby, the expression of β-
galactosidase is under control of the endogenous Ebf3 promoter and recapitulates 
the expression of Ebf3. 
Staining for β-galactosidase in mouse embryos demonstrates that Ebf3 is strongly 
expressed in the olfactory epithelium, neuronal tissues, adipocytes and skeletal 
muscles, particularly the diaphragm. However, Ebf3 is not expressed in lung, which 
is an important clue for supporting our hypothesis on the biological function of Ebf3.  
  
Deficiency of Ebf3 did not result in any morphological difference during embryonic 
development. However, Ebf3-/- mice showed gasping respiration and cyanosis after 
birth. Eventually, all Ebf3-/- mice died within a few hours after birth because of 
respiratory failure, raising the question for the reason of this phenotype.  
Unfolding of the lung at birth is important to facilitate normal breathing and delivery of 
oxygen to the body. Ebf3-/- mice have a defect in the unfolding of the lung, preventing 
a normal oxygen uptake, and explaining the postnatal cyanosis. However, this 
cannot be a defect intrinsic to the lung, as it does not express Ebf3 and unfolding at 
birth is not achieved by the lung itself. The diaphragm and the rib cage are the main 
structures required for the unfolding at birth and a normal breathing process. Since 
the formation of bone and cartilage are unaffected by the loss of Ebf3, the expression 
and function of Ebf3 in diaphragm and muscle were analyzed to potentially explain 
this respiratory failure.  
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7.5. Biochemical mechanisms of muscle function 
 
Skeletal muscles consist of bundles of muscle fibers, and the sliding of two sets of 
fibers, which are thin actin filament and thick myosin filament, produces force and 
movement (Herzog, 2013). The molecular mechanism of muscle function is 
summarized in the cross-bridge cycle, which is explained below (Fig. 10). 
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Figure 10. The cross-bridge cycle of muscle filaments. 
The cross-bridge cycle is mainly divided into four steps. (A) Formation of the cross-bridge. 
Ca2+ binding to troponin induces the dissociation of troponin and tropomyosin, allowing actin-
myosin cross-bridge formation. (B) Power stroke. After ATP hydrolysis, the cross-bridge 
generates the power stroke by release of Pi inducing the sliding myosin along the actin 
filament towards the center of the sarcomere. (C) ADP release. After the power stroke, ADP 
is released from the myosin head. (D) Detachment of cross-bridge. Another ATP binds to the 
myosin head thereby detaching it from actin (figure modified from Coirault et al., 1999b).   
 
 
The formation of the cross-bridge is initiated when calcium ions are released from the 
SR and bind to the troponin associated with tropomyosin. This causes tropomyosin 
to dissociate from actin allowing activated myosin heads to attach to the binding site 
in actin. The hydrolysis of ATP into ADP and an inorganic phosphate (Pi) initiates the 
tight cross-bridge bond between actin and myosin. By release of Pi from the myosin 
head, the power stroke generates force to slide actin filaments towards the center of 
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the sarcomere. After the power stroke, the release of ADP allows new ATP binding to 
the myosin head causing rapid detachment of myosin from the actin. This cross-
bridge cycle induces muscle contraction, contrarily muscle relaxation occurs by 
dissociation of calcium ions from troponin (Coirault et al., 1999a, 1999b; Berchtold et 
al., 2000; Fig. 10). Thereby, decreasing the Ca2+ concentration is essential to 
mediate muscle relaxation. When Ca2+ is removed, troponin and tropomyosin 
associate again resulting in the inhibition of the cross-bridge formation due to 
blocking of the binding site for activated myosin heads (Davis and Tikunova, 2008). 
Taken together, the main trigger of muscle contraction and relaxation is the directed 
transport of Ca2+ between the cytoplasm and its cellular storage compartment, the 
sarcoplasmic reticulum. 
 
The calcium-transport processes are performed by two key molecular mediators, 
ryanodine receptor and SERCA proteins (James et al., 2011). 
The ryanodine receptor plays a role as the sarcoplasmic reticulum calcium channel 
which releases Ca2+ for inducing muscle contraction. Increasing density of ryanodine 
receptors in muscle cells is an important determinant of strength and endurance of 
muscle contraction (Anttila et al., 2008; James et al., 2011). 
SERCA proteins, which are sarcoplasmic reticulum Ca2+ pumps, are responsible for 
the transport of Ca2+ from the cytoplasm to the SR to allow muscle relaxation. They 
are regulated by ATP supply and the phosphorylation of phospholamban (Coirault et 
al., 1999b; Berchtold et al., 2000). Unphosphorylated phospholamban binds to 
SERCA proteins and decreases their affinity to Ca2+. Two different isoforms of 
SERCA, SERCA1 and SERCA2a1, are expressed in fast-twitch and slow-twitch 
muscle fibers. The SERCA1 has a higher capacity of SR Ca2+ uptake than 
SERCA2a1, which is associated with a higher frequency of muscle relaxation 
(Coirault et al., 1999b).  
 
In the second publication (Nature Comm., 2014), the expression of various important 
genes implicated in muscle contraction and relaxation were analyzed. For example, 
Tnnc1 (troponin C type I), Tpm1 (tropomyosin 1), MyBP-C (myosin binding protein C) 
and myosin heavy chain isoforms do not show differences in expression in Ebf3-
deficient diaphragm. However, the expression of Atp2a1 encoding for SERCA1 is 
significantly reduced in absence of Ebf3.  
Interestingly, the loss of Ebf3 and Atp2a1 results in similar phenotypic defects. 
Expression of Atp2a1 can rescue the respiratory failure of Ebf3-deficient mice 
demonstrating the importance of Atp2a1 as an Ebf3 target gene in muscle relaxation. 
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Furthermore, Ebf3 binds to consensus sites in the promoter of Atp2a1 as shown by 
EMSA and ChIP assay, and that it can transactivate the Atp2a1 promoter via these 
binding sites. Moreover, Ebf3 alone is not enough to induce the expression of 
endogenous Atp2a1 but together with MyoD it shows strong synergy to induce 
Atp2a1. Likewise, MyoD can bind to its consensus site in the Atp2a1 promoter in the 
absence of Ebf3, demonstrating its pioneering activity in this cellular and molecular 
context. In summary, we uncovered a new role for Ebf3 in muscle biology and were 
able to describe the molecular mechanism. 
 
In the Ebf3-deficient mice, SERCA1 is barely detectable in the diaphragm. 
Interestingly, however, its expression level does not change in other skeletal 
muscles. Other Ebf family factors in both diaphragm and skeletal muscle were tested 
for potential co-expression, and Ebf1 was found to be strongly expressed in other 
skeletal muscles. Moreover, the down-regulation of Ebf1 causes a reduction of 
Atp2a1 expression in skeletal muscle. Because Ebf1 is a member of the highly 
homologous Ebf gene family, the genetic redundancy between Ebf1 and Ebf3 might 
explain the lack of phenotype in other skeletal muscles. Although diaphragm is a 
skeletal muscle, the mechanisms leading to different levels of Ebf expression 
between the diaphragm and other skeletal muscles are not clear. 
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8. Outlook 	  
I. A new strategy for genomic manipulation 
 
Since RNA interference (RNAi) has been discovered in C. elegans for regulating 
gene expression, RNAi-based mechanisms have been widely used as a powerful 
tool to study gene function in a variety of organisms and cells (Kim & Rossi, 2008; 
Boutros and Ahringer, 2008).  
However, even if applied successfully, inherent problems of this technology remain. 
The most severe among those are the difficulties to control for off-target effects and 
the fact that it is a down-regulation, not a complete genomic loss. Therefore, when 
analyzing phenotypes from an RNAi-based down-regulation, it is virtually impossible 
to determine if the remaining protein prevents the manifestation of a complete 
phenotype or if off-target effects contribute. This situation is even more complicated 
in vivo as it requires the generation of several control mouse strains, increasing the 
financial and time burden. Therefore, such studies would benefit greatly from a 
genetically clearly defined situation.  
 
To overcome intrinsic limitations of RNAi, the newly discovered CRISPR-Cas9 
system offers big advantages in manipulating the genome. Cas9 is a RNA-guided 
endonuclease that can perform site-specific DNA-targeting and cleaving based on a 
complementary sequence. CRISPRs are clustered, regularly interspaced, short 
palindromic repeats of RNA that function as guiding RNAs for Cas9 (Sander & 
Joung, 2014). This nuclease-based method offers an easy, rapid and efficient way of 
modifying or deleting endogenous genes, greatly improving the manipulation of the 
genome of cells or organisms (Baker, 2014; Jia et al., 2014). Therefore, rather than 
trying to improve the RNAi-based approach, we would suggest to apply this new 
technology to delete several Ebf genes in a tissue-specific manner. 
 
 
II. Brody’s disease and Ebf protein family 
 
Brody disease is a rare genetic myopathy that shows functional impairments of 
skeletal muscle like a delay in muscle relaxation after contraction and cramped 
muscles (Brody, 1969). Some cases of this disease are due to the mutation of 
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ATP2A1 that reduce SERCA1 activity or expression (Taylor et al., 1988; Voermans 
et al., 2012). However, not all Brody’s patients have defects in the ATP2A1 gene 
even though they show loss of SERCA1 activity or expression (Odermatt et al. 1996; 
Zhang et al., 1995). These patients, without ATP2A1 mutations, are classified as 
Brody syndrome and it is estimated that they constitute approximately 50% of all 
Brody’s cases (Karpati et al., 1986; Voermans et al., 2012). In the second publication 
(Nature Comm, 2014), we demonstrate a significant reduction of Serca1 expression 
in the diaphragm of Ebf3-deficient mice resulting in an impairment of muscle 
relaxation. Since binding sites for Ebf proteins are also present in the promoter of 
human Atp2a1, we propose Ebf3 as a potential factor involved in the development of 
Brody syndrome. Therefore, samples from Brody’s patients should be analyzed for 
potential mutations of their Ebf binding sites. 
 
Furthermore, we show that Ebf3 directly regulates the expression of Atp2a1 in the 
diaphragm. While Ebf3 shows the strongest expression in diaphragm, in other 
skeletal muscles, Ebf1 is the most significantly expressed Ebf member. Moreover, 
Ebf1-deficient mice also show down-regulation of Atp2a1 in skeletal muscle. Taken 
together, this raises the question why the expression patterns of Ebf family members 
are different between diaphragm and other skeletal muscles.  
Therefore, we suggest testing cells from Ebf3-/- mice with an Ebf1 retroviral approach 
or analyzing Ebf1 and Ebf3 double knock-out transgenic mice whether the functional 
damage of Ebf3-/- diaphragm can be rescued or is synergistic. 
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